Processing 00000000.tx.1: Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease  Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease D. 

Phrase: "Synergy between the genes"

Phrase: "for butyrylcholinesterase K variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: "and"

Phrase: "apolipoprotein E4 in late-onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "Alzheimer's disease  Synergy between the genes"

Phrase: "for butyrylcholinesterase K variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: "and"

Phrase: "apolipoprotein E4 in late-onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "Alzheimer's disease D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.2: J. 

Phrase: "J."
Processing 00000000.tx.3: Lehmann, C. 

Phrase: "Lehmann,"

Phrase: "C."
Processing 00000000.tx.4: Johnston and A. 

Phrase: "Johnston"

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.5: D. 

Phrase: "D."
Processing 00000000.tx.6: Smith* Oxford Project to Investigate Memory and Ageing (OPTIMA), University Department of Pharmacology, Mansfield Rd, Oxford OX1 3QT, UK and Radcliffe Infirmary, Woodstock Rd, Oxford OX2 6HE, UK Received July 3, 1997; 

Phrase: "Smith"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "* Oxford Project to Investigate Memory and Ageing (OPTIMA),"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   795   C0001811:Ageing [Organism Function]
   795   C0025260:Memory [Mental Process]
   795   C0700327:memory [Finding]
   795   C1292732:investigate [Functional Concept]
   795   C1706377:Memory [Manufactured Object]
   795   C1709701:Project [Conceptual Entity]
   740 E C0679055:mnemonic [Mental Process]

Phrase: "University Department of Pharmacology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041740:University [Manufactured Object,Organization]
   770   C1704729:Department [Organization]

Phrase: "Mansfield Rd,"

Phrase: "Oxford OX1 3QT,"

Phrase: "UK"

Phrase: "and"

Phrase: "Radcliffe Infirmary,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0221502:infirmary [Health Care Related Organization]

Phrase: "Woodstock Rd,"

Phrase: "Oxford OX2 6HE,"

Phrase: "UK"

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "July 3,"

Phrase: "1997"

Phrase: ";"
Processing 00000000.tx.7: Revised and Accepted July 31, 1997 The allelic frequency of the gene for the K variant of butyrylcholinesterase (BCHE-K) was 0.17 in 74 subjects with late-onset (age >65 years) histopathologically diagnosed Alzheimer's disease (AD), which was higher than the frequencies in 104 elderly control subjects (0.09), in 14 early-onset cases of confirmed AD (0.07) and in 29 confirmed cases of other dementia (0.10). 

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted July 31,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0450355:31 [Intellectual Product]
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1997"

Phrase: "The allelic frequency of the gene"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0017270:allelic frequency [Quantitative Concept]
           Gene Frequency
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "for the K variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "of butyrylcholinesterase (BCHE-K)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "was"

Phrase: "0.17 in 74 subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "with late-onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205087:Late [Temporal Concept]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "(age >65 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C1510829:Age-Years [Temporal Concept]
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "histopathologically diagnosed Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "(AD"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "higher than the frequencies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   786   C0205212:High frequency [Temporal Concept]
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "in 104 elderly control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: "(0.09"

Phrase: ")"

Phrase: ","

Phrase: "in 14 early-onset cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]

Phrase: "of confirmed AD (0.07"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0521093:confirmed [Qualitative Concept]
   812   C0750484:Confirmed [Idea or Concept]
   779 E C1456348:Confirm [Qualitative Concept]

Phrase: ")"

Phrase: "and in 29 confirmed cases of other dementia"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   744   C0011265:dementia [Mental or Behavioral Dysfunction]
   744   C0497327:Dementia [Mental or Behavioral Dysfunction]
   744   C0521093:confirmed [Qualitative Concept]
   744   C0750484:Confirmed [Idea or Concept]
   744   C0868928:Cases [Functional Concept]
   744   C1515981:And [Idea or Concept]
   744   C1533148:Cases [Quantitative Concept]
   711 E C1456348:Confirm [Qualitative Concept]
   711 E C1706255:CASE [Medical Device]
   711 E C1706256:Case [Conceptual Entity]

Phrase: "(0.10"

Phrase: ")."
Processing 00000000.tx.8: The association of BCHE-K with late-onset AD was limited to carriers of the [epsilon]4 allele of the apolipoprotein E gene (APOE), among whom the presence of BCHE-K gave an odds ratio of confirmed late-onset AD of 6.9 (95% C.I. 1.65-29) in subjects >65 years and of 12.8 (1.9-86) in subjects >75 years. 

Phrase: "The association of BCHE-K"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "with late-onset AD"

Phrase: "was"

Phrase: "limited to carriers of the [epsilon"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   753   C0007294:carriers [Finding]
   753   C0439098:Epsilon [Intellectual Product]
   753   C0439801:Limited [Functional Concept]
   753   C3542948:Limited [Intellectual Product]
   719 E C0560175:Carrier [Finding]
   719 E C1549649:Limit [Idea or Concept]
   719 E C1706209:Carrier [Medical Device]
   719 E C2349209:Limit [Conceptual Entity]
   719 E C3273162:Carrier [Intellectual Product]

Phrase: "]4 allele of the apolipoprotein E gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   835   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   748   C0002085:Allele [Gene or Genome]
           allelic gene

Phrase: "(APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "among whom"

Phrase: "the presence of BCHE-K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "an odds ratio of confirmed late-onset AD of 6.9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0028873:Odds Ratio [Quantitative Concept]
   738   C0456603:Ratio [Quantitative Concept]
   738   C1547037:Ratio [Intellectual Product]

Phrase: "(95% C.I. 1.65-29"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   839   C0063251:I 65 [Organic Chemical,Pharmacologic Substance]
   827   C0963236:I-1 [Amino Acid, Peptide, or Protein,Receptor]
   827   C1425233:I-1 [Gene or Genome]
   827   C3540559:I-1 [Gene or Genome]
   799   C0021966:I- [Inorganic Chemical]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0450385:65 [Intellectual Product]

Phrase: ")"

Phrase: "in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: ">65 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "and of 12.8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "(1.9-86"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: ">75 years."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.9: In APOE[epsilon]4 carriers over 75 years, only 1/22 controls, compared with 10/24 confirmed late-onset AD cases, had BCHE-K. 

Phrase: "In APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 carriers over 75 years,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0007294:carriers [Finding]
   726 E C0560175:Carrier [Finding]
   726 E C1706209:Carrier [Medical Device]
   726 E C3273162:Carrier [Intellectual Product]

Phrase: "only 1/22 controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0243148:control [Qualitative Concept]
   779   C1550141:Control [Substance]
   779   C1882979:Control [Conceptual Entity]
   779   C2587213:Control [Functional Concept]
   779   C3274648:Control [Qualitative Concept]

Phrase: "compared with 10/24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "late-onset AD cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]

Phrase: "had"

Phrase: "BCHE-K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]
Processing 00000000.tx.10: We suggest that BCHE-K, or a nearby gene on chromosome 3, acts in synergy with APOE[epsilon]4 as a susceptibility gene for late-onset AD. 

Phrase: "We"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that BCHE-K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "or"

Phrase: "a nearby gene on chromosome 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0079429:A Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]

Phrase: "acts in synergy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "with APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 as a susceptibility gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0919453:Susceptibility Gene [Gene or Genome]
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0017337:Gene [Gene or Genome]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "for late-onset AD."
Processing 00000000.tx.11: INTRODUCTION Butyrylcholinesterase (BChE) is expressed in most human tissues (1 ), yet its function is unknown. 

Phrase: "INTRODUCTION Butyrylcholinesterase (BChE)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "is"

Phrase: "expressed in most human tissues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0440744:human tissues [Tissue]
   760   C0040300:Tissues [Tissue]
   760   C0086418:Human [Human]
   726 E C1547928:Tissue [Intellectual Product]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "yet"

Phrase: "its function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.12: BChE activity in the brain increases with age over 60 years and is elevated in Alzheimer's disease (AD) (2 ,3 ). 

Phrase: "BChE activity in the brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1149831:butyrylcholinesterase activity [Molecular Function]
   797   C0443158:Brain activity [Physiologic Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "increases with age"
Meta Candidates (Total=9; Excluded=7; Pruned=0; Remaining=2)
   790   C0001779:Age [Organism Attribute]
   790   C0442805:Increase [Functional Concept]
   734 E C1517378:Gain [Quantitative Concept]
   706 E C0205217:Increased [Quantitative Concept]
   706 E C0439661:Acquired [Temporal Concept]
   706 E C0442808:Increasing [Functional Concept]
   706 E C1301820:Obtain [Functional Concept]
   706 E C1706701:Acquire [Activity]
   706 E C3245488:acquired [Intellectual Product]

Phrase: "over 60 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "is"

Phrase: "elevated in Alzheimer's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205250:Elevated [Qualitative Concept]
   770   C3163633:Elevated [Qualitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(AD) (2 ,"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: Histochemically reactive BChE is associated with amyloid plaques and neurofibrillary tangles and with amyloid angiopathy in AD (4 -8 ). 

Phrase: "Histochemically reactive BChE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "is"

Phrase: "associated with amyloid plaques"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   833   C2936349:Plaques, Amyloid [Acquired Abnormality]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C0011389:Plaque [Disease or Syndrome]
   737 E C0332461:Plaque [Finding]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and with amyloid angiopathy"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C2931784:Amyloid angiopathy [Disease or Syndrome]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0042373:Angiopathy [Disease or Syndrome]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1515981:And [Idea or Concept]

Phrase: "in AD (4 -8"

Phrase: ")."
Processing 00000000.tx.14: We have looked for possible associations of AD with two of the more common human variants of the gene for BChE (BCHE), the atypical allele and the K variant (BCHE-K). 

Phrase: "We"

Phrase: "have"

Phrase: "looked for possible associations of AD"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0004083:Associations [Mental Process]
   753   C0332149:Possible [Qualitative Concept]
   753   C1705910:Possible [Qualitative Concept]
   753   C2362652:Possible [Qualitative Concept]
   719   C0233426:look [Organism Attribute]
   719 E C0439849:Association [Qualitative Concept]
   719 E C0596306:Association [Phenomenon or Process]
   719 E C0699792:association [Social Behavior]

Phrase: "with two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "of the more common human variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:variants [Qualitative Concept]

Phrase: "of the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "for BChE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "(BCHE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:BCHE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BCHE [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "the atypical allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "the K variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "(BCHE-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.15: The latter has a point mutation at nucleotide 1615 (GCA -> ACA) which changes Ala539 to threonine and the catalytic activity is reduced by a third (9 ). 

Phrase: "The latter"

Phrase: "has"

Phrase: "a point mutation at nucleotide 1615"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   790   C2924612:A point [Body Location or Region]
   753   C0026882:Mutation [Genetic Function]
   753   C1552961:Point [Quantitative Concept]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]
   753   C2347617:point [Quantitative Concept]

Phrase: "(GCA -> ACA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0149561:ACA [Body Part, Organ, or Organ Component]

Phrase: "which"

Phrase: "changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "Ala539 to threonine"

Phrase: "and"

Phrase: "the catalytic activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0243102:catalytic activity [Molecular Function]
  1000   C1264638:Catalytic activity [Functional Concept]
  1000   C1547012:*Catalytic Activity [Quantitative Concept]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "reduced by a third"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205437:Third [Quantitative Concept]
   770   C0392756:Reduced [Qualitative Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.16: BCHE-K is thought to have an allelic frequency of ~0.12 in Caucasians (9 -11 ). 

Phrase: "BCHE-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "an allelic frequency of ~0.12 in Caucasians"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0017270:allelic frequency [Quantitative Concept]
   767   C0635218:AN 12 [Organic Chemical]
   744   C0007457:Caucasians [Population Group]
   744   C0043157:Caucasians [Population Group]
   744   C0376249:frequency [Quantitative Concept]
   744   C0439603:Frequency [Temporal Concept]
   744   C0871396:Frequency [Quantitative Concept]
   744   C1561548:Frequency [Qualitative Concept]
   744   C1705502:Frequency [Quantitative Concept]

Phrase: "(9 -11"

Phrase: ")."
Processing 00000000.tx.17: RESULTS After 178 subjects had been genotyped, three control subjects out of 104 and three AD cases out of 74 were identified as heterozygotes for the atypical BCHE allele. 

Phrase: "RESULTS After 178 subjects"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "had"

Phrase: "been"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: ","

Phrase: "three control subjects out of 104"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "three AD cases out of 74"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "identified as heterozygotes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0019425:Heterozygotes [Organism Attribute]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "for the atypical BCHE allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.18: Thus, no association was found between histopathologically confirmed AD and the atypical allele of BCHE. 

Phrase: "Thus,"

Phrase: "no association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "found between histopathologically confirmed AD"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0150312:Found [Quantitative Concept]
   760   C0521093:confirmed [Qualitative Concept]
   760   C0750484:Confirmed [Idea or Concept]
   726 E C0243095:Find [Finding]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "the atypical allele of BCHE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.19: Two out of the six atypical BCHE heterozygotes were carriers of BCHE-K. 

Phrase: "Two out of the six atypical BCHE heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205448:Two [Quantitative Concept]

Phrase: "were"

Phrase: "carriers of BCHE-K."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0007294:carriers [Finding]
   756 E C0560175:Carrier [Finding]
   756 E C1706209:Carrier [Medical Device]
   756 E C3273162:Carrier [Intellectual Product]
Processing 00000000.tx.20: Altogether, 282 Caucasian subjects were genotyped for BCHE-K and for APOE alleles. 

Phrase: "Altogether,"

Phrase: "282 Caucasian subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "genotyped for BCHE-K"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]
   756   C0017431:Genotype [Organism Attribute]

Phrase: "and for APOE alleles."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002085:Alleles [Gene or Genome]
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]
   770   C1515981:And [Idea or Concept]
Processing 00000000.tx.21: BCHE-K was more common in late-onset AD cases than in early-onset AD cases, other dementias or controls (Table 1 ). 

Phrase: "BCHE-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "was"

Phrase: "more common in late-onset AD cases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205214:Common [Quantitative Concept]
   748   C1522138:Common [Functional Concept]
   748   C3245511:common [Intellectual Product]

Phrase: "than"

Phrase: "in early-onset AD cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]

Phrase: "other dementias"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0497327:Dementias [Mental or Behavioral Dysfunction]
   966 E C0011265:dementia [Mental or Behavioral Dysfunction]
   893 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "or"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.22: For subjects aged over 65, the allelic frequency of BCHE-K was 0.09 in 104 controls and 0.17 in 74 confirmed AD cases, giving an odds ratio of AD of 2.15 (Table 2 ). 

Phrase: "For subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "aged over 65,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0001779:Aged [Organism Attribute]
   790   C0001792:Aged [Population Group]
   790   C0450385:65 [Intellectual Product]
   790   C1999167:aged [Population Group]

Phrase: "the allelic frequency of BCHE-K"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0017270:allelic frequency [Quantitative Concept]
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]

Phrase: "was"

Phrase: "0.09 in 104 controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "0.17 in 74 confirmed AD cases,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0521093:confirmed [Qualitative Concept]
   748   C0750484:Confirmed [Idea or Concept]
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1456348:Confirm [Qualitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "giving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "an odds ratio of AD of 2.15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0028873:Odds Ratio [Quantitative Concept]
   744   C0456603:Ratio [Quantitative Concept]
   744   C1547037:Ratio [Intellectual Product]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.23: Most of this association appeared to be due to subjects over 75 years old, for whom the frequency of BCHE-K was 0.08 in 68 controls and 0.19 in 36 confirmed AD cases ([chi]2 with Yates' correction = 4.7; 

Phrase: "Most of this association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0004083:Association [Mental Process]
   770   C0205393:Most [Quantitative Concept]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be due to subjects"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0678226:Due to [Functional Concept]
           due
   770   C2987476:Be [Conceptual Entity]
   770   C3146286:Due [Idea or Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "over 75 years old,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0580836:Old [Temporal Concept]

Phrase: "for whom"

Phrase: "the frequency of BCHE-K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0376249:frequency [Quantitative Concept]
   770   C0439603:Frequency [Temporal Concept]
   770   C0871396:Frequency [Quantitative Concept]
   770   C1561548:Frequency [Qualitative Concept]
   770   C1705502:Frequency [Quantitative Concept]

Phrase: "was"

Phrase: "0.08 in 68 controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0450387:68 [Intellectual Product]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "0.19 in 36 confirmed AD cases"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   774   C0648082:AD 19 [Organic Chemical,Pharmacologic Substance]
   748   C0521093:confirmed [Qualitative Concept]
   748   C0750484:Confirmed [Idea or Concept]
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1456348:Confirm [Qualitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "("

Phrase: "[chi]2 with Yates' correction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1705565:CORRECTION [Intellectual Product]
   760   C1720589:Chi [Intellectual Product]
   760   C1947976:Correction [Functional Concept]

Phrase: "= 4.7"

Phrase: ";"
Processing 00000000.tx.24: P = 0.03), giving an odds ratio of AD of 2.7 (Table 2 ). 

Phrase: "P = 0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "giving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "an odds ratio of AD of 2.7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0028873:Odds Ratio [Quantitative Concept]
   744   C0456603:Ratio [Quantitative Concept]
   744   C1547037:Ratio [Intellectual Product]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.25: There were insufficient cases for this trend with age to reach significance, but nevertheless we thought it helpful to show data for the >75 years subgroup as well as for all subjects >65 years in Table 2 . Taking account of an individual's carrier status for APOE [epsilon]4 produced striking results. 

Phrase: "There"

Phrase: "were"

Phrase: "insufficient cases for this trend"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "with age to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "significance,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]

Phrase: "but"

Phrase: "nevertheless"

Phrase: "we"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "it helpful to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   789   C0018896:Help [Social Behavior]
   789   C1552861:help [Idea or Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "data for the >75 years subgroup"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "as well as for all"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205170:Well [Qualitative Concept]
   760   C3146287:Well [Manufactured Object]

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: ">65 years in Table 2 . Taking account of an individual's carrier status"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   736   C0439234:years [Temporal Concept]
   703 E C0439508:/year [Temporal Concept]

Phrase: "for APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 produced striking results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1274040:Result [Functional Concept]
   779   C1546471:Result [Idea or Concept]
   779   C2825142:Result [Finding]
Processing 00000000.tx.26: In subjects >65 years without APOE [epsilon]4, the allelic frequency of BCHE-K was 0.14 in 22 confirmed AD cases and 0.11 in 72 controls. 

Phrase: "In subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: ">65 years without APOE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439234:years [Temporal Concept]
   737 E C0439508:/year [Temporal Concept]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4,"

Phrase: "the allelic frequency of BCHE-K"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0017270:allelic frequency [Quantitative Concept]
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]

Phrase: "was"

Phrase: "0.14 in 22 confirmed AD cases"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0521093:confirmed [Qualitative Concept]
   748   C0750484:Confirmed [Idea or Concept]
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1456348:Confirm [Qualitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "0.11 in 72 controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.27: There was thus no association of BCHE-K with late-onset AD in subjects lacking an APOE [epsilon]4 allele. 

Phrase: "There"

Phrase: "was"

Phrase: "thus"

Phrase: "no association of BCHE-K"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "with late-onset AD"

Phrase: "in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "an APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.28: In APOE [epsilon]4 carriers, however, BCHE-K allelic frequencies in subjects aged >65 years were 0.18 in 52 confirmed AD cases and only 0.03 in 32 controls; 

Phrase: "In APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 carriers,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "however,"

Phrase: "BCHE-K allelic frequencies in subjects"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0017270:allelic frequency [Quantitative Concept]
   760   C0439603:Frequencies [Temporal Concept]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]
   726 E C1705502:Frequency [Quantitative Concept]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: ">65 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "were"

Phrase: "0.18 in 52 confirmed AD cases"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0521093:confirmed [Qualitative Concept]
   748   C0750484:Confirmed [Idea or Concept]
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1456348:Confirm [Qualitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "only 0.03 in 32 controls"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205171:Only [Quantitative Concept]
   753   C1720467:Only [Intellectual Product]
   719   C0243148:control [Qualitative Concept]
   719   C1550141:Control [Substance]
   719   C1882979:Control [Conceptual Entity]
   719   C2587213:Control [Functional Concept]
   719   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.29: in subjects aged >75 years the frequencies were 0.23 in 24 confirmed AD cases and 0.02 in 22 controls. 

Phrase: "in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: ">75 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "the frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0439603:Frequencies [Temporal Concept]
   966 E C0376249:frequency [Quantitative Concept]
   966 E C0871396:Frequency [Quantitative Concept]
   966 E C1561548:Frequency [Qualitative Concept]
   966 E C1705502:Frequency [Quantitative Concept]
   916 E C0332183:Frequent [Temporal Concept]

Phrase: "were"

Phrase: "0.23 in 24 confirmed AD cases"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0450348:23 [Quantitative Concept]
   748   C0521093:confirmed [Qualitative Concept]
   748   C0750484:Confirmed [Idea or Concept]
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1456348:Confirm [Qualitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "0.02 in 22 controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.30: These results gave odds ratios of confirmed AD of 6.9 and 12.8 for BCHE-K in APOE [epsilon]4 carriers aged >65 years and >75 years, respectively (Table 2 ). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "odds ratios of confirmed AD of 6.9"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0028873:Odds Ratios [Quantitative Concept]
   744   C0456603:Ratios [Quantitative Concept]
   744   C1610540:*Ratios [Quantitative Concept]
   711 E C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "12.8 for BCHE-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "in APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: ">65 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "and >"

Phrase: "75 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "respectively"

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.31: For comparison, we give in Table 3 the odds ratios of confirmed AD for APOE [epsilon]4 in BCHE-K carriers. 

Phrase: "For comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "we"

Phrase: "give in Table 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C1947971:Give [Functional Concept]

Phrase: "the odds ratios of confirmed AD"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratios [Quantitative Concept]
   753   C0456603:Ratios [Quantitative Concept]
   753   C1610540:*Ratios [Quantitative Concept]
   719 E C1547037:Ratio [Intellectual Product]

Phrase: "for APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 in BCHE-K carriers."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007294:carriers [Finding]
   770   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]
   737 E C0560175:Carrier [Finding]
   737 E C1706209:Carrier [Medical Device]
   737 E C3273162:Carrier [Intellectual Product]
Processing 00000000.tx.32: It can be seen that an individual's BCHE-K status markedly influences the strength of the effect of APOE [epsilon]4. 

Phrase: "It"

Phrase: "can"

Phrase: "be"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "that"

Phrase: "an individual's BCHE-K status markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449438:Status [Qualitative Concept]

Phrase: "influences"

Phrase: "the strength of the effect of APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0237897:Strength [Quantitative Concept]
   748   C0808080:Strength [Idea or Concept]
   748   C1705922:Strength [Qualitative Concept]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4."
Processing 00000000.tx.33: Table 4 shows the striking differences between cases and controls in the proportions of subjects who carry both BCHE-K and APOE [epsilon]4 alleles. 

Phrase: "Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the striking differences between cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "controls in the proportions of subjects"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C1709707:Proportion [Quantitative Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "who"

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "both BCHE-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "and"

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 alleles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]
Processing 00000000.tx.34: All these findings indicated an interaction between BCHE-K and APOE [epsilon]4, which we confirmed by logistic regression analysis. 

Phrase: "All"

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "an interaction between BCHE-K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4,"

Phrase: "which"

Phrase: "we"

Phrase: "confirmed by logistic regression analysis."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   862   C0681925:logistic regression analysis [Research Activity]
   806   C0034980:Regression Analysis [Intellectual Product]
   806   C0206031:Logistic Regression [Research Activity]
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0242415:logistic [Occupational Activity]
   760   C0684320:Regression [Pathologic Function]
   760   C0684321:Regression [Mental Process]
   760   C0750484:Confirmed [Idea or Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.35: We fitted several logistic regression models to the data and found that a parsimonious model with only APOE [epsilon]4, BCHE-K and their interaction gave an adequate fit (residual deviance: 5.5 on 4 degrees of freedom). 

Phrase: "We"

Phrase: "fitted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036572:Fit [Sign or Symptom]
  1000   C0424576:Fit [Finding]
  1000   C2349186:Fit [Activity]

Phrase: "several logistic regression models to the data"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0206031:Logistic Regression [Research Activity]
   774   C0023965:Logistic Models [Intellectual Product,Quantitative Concept]
   748   C0242415:logistic [Occupational Activity]
   748   C0684320:Regression [Pathologic Function]
   748   C0684321:Regression [Mental Process]
   748   C3161035:Models [Intellectual Product]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "a parsimonious model with only APOE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4,"

Phrase: "BCHE-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "and"

Phrase: "their interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "an adequate fit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036572:Fit [Sign or Symptom]
   861   C0424576:Fit [Finding]
   861   C2349186:Fit [Activity]

Phrase: "(residual deviance"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0679498:deviance [Social Behavior]
   789 E C0205161:deviant [Qualitative Concept]
   789 E C0683307:deviant [Individual Behavior]

Phrase: ":"

Phrase: "5.5 on 4 degrees of freedom"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0450380:5/5 [Quantitative Concept]
   748   C0016694:Freedom [Idea or Concept]
   748   C0439084:>5 [Quantitative Concept]
   748   C0449286:degrees [Quantitative Concept]
   748   C0542560:degrees [Intellectual Product]
   748   C0728893:+5 [Quantitative Concept]
   714 E C0441889:Degree [Qualitative Concept]
   714 E C1561545:degree [Quantitative Concept]
   714 E C2348088:Degree [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.36: In this model, APOE [epsilon]4 and its interaction with BCHE-K were significantly associated with AD, but BCHE-K by itself was not. 

Phrase: "In this model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4"

Phrase: "and"

Phrase: "its interaction with BCHE-K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "were"

Phrase: "significantly"

Phrase: "associated with AD,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "but"

Phrase: "BCHE-K by itself"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "was"

Phrase: "not."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.37: Table 1 Allelic frequencies of BCHE-K and APOE [epsilon]4  No. of subjects F:M ratio Mean agea BCHE-K allele frequency APOE [epsilon]4 allele frequency Controls >65 years 104 1.26 78.1 0.09 0.16 All LOAD cases 105 1.50 80.9 0.16* 0.40** All EOAD cases 44 1.10 65.9 0.09 0.42** Confirmed LOAD 74 1.39 81.4 0.17* 0.41** Confirmed EOAD 14 2.50 67.8 0.07 0.54** Confirmed other dementia 29 0.81 76.8 0.10 0.19 LOAD and EOAD are respectively late-onset (>65 years) and early-onsetAlzheimer's disease. 

Phrase: "Table 1 Allelic frequencies of BCHE-K"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   773   C0017270:allelic frequency [Quantitative Concept]
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4"

Phrase: "No."

Phrase: "of subjects F:M ratio Mean agea BCHE-K allele frequency APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0523511:APOE [Laboratory Procedure]
   790   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 allele frequency"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0017270:Allele Frequency [Quantitative Concept]
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ">65 years 104 1.26 78.1 0.09 0.16"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   788   C0439234:years [Temporal Concept]
   788   C0450385:65 [Intellectual Product]
   755 E C0439508:/year [Temporal Concept]

Phrase: "All"

Phrase: "LOAD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]

Phrase: "cases 105 1.50 80.9 0.16"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0868928:Cases [Functional Concept]
   793   C1533148:Cases [Quantitative Concept]
   760 E C1706255:CASE [Medical Device]
   760 E C1706256:Case [Conceptual Entity]

Phrase: "* 0.40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "*"

Phrase: "*"

Phrase: "All EOAD cases 44 1.10 65.9 0.09 0.42"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   788   C0450385:65 [Intellectual Product]
   788   C0868928:Cases [Functional Concept]
   788   C1533148:Cases [Quantitative Concept]
   755 E C1706255:CASE [Medical Device]
   755 E C1706256:Case [Conceptual Entity]

Phrase: "*"

Phrase: "* Confirmed LOAD 74 1.39 81.4 0.17"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   791   C0521093:confirmed [Qualitative Concept]
   791   C0750484:Confirmed [Idea or Concept]
   791   C1550025:Load [Idea or Concept]
   791   C1704782:Load [Manufactured Object]
   791   C1708715:Load [Activity]
   758 E C1456348:Confirm [Qualitative Concept]

Phrase: "* 0.41"

Phrase: "*"

Phrase: "* Confirmed EOAD 14 2.50 67.8 0.07 0.54"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   788   C0521093:confirmed [Qualitative Concept]
   788   C0750484:Confirmed [Idea or Concept]
   755 E C1456348:Confirm [Qualitative Concept]

Phrase: "*"

Phrase: "* Confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "other dementia 29 0.81 76.8 0.10 0.19 LOAD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   788   C1550025:Load [Idea or Concept]
   788   C1704782:Load [Manufactured Object]
   788   C1708715:Load [Activity]

Phrase: "and"

Phrase: "EOAD"

Phrase: "are"

Phrase: "respectively late-onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205087:Late [Temporal Concept]
   827   C0332162:Onset [Qualitative Concept]

Phrase: "("

Phrase: ">65 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "early-onsetAlzheimer's disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   913   C0679245:early disease [Temporal Concept]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.38: For BCHE-K, each of the above groups was in exact Hardy-Weinberg equilibrium. 

Phrase: "For BCHE-K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "each of the above groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1457900:Each [Quantitative Concept]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "was in exact Hardy-Weinberg equilibrium."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0014653:Equilibrium [Organism Function]
   753   C0043194:WAS [Disease or Syndrome]
   753   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1421478:WAS [Gene or Genome]
   753   C1547026:Equilibrium [Quantitative Concept]
   753   C2828393:Exact [Qualitative Concept]
Processing 00000000.tx.39: *P <0.03, **P <0.0001 ([chi]2 with Yates' correction) versus controls. 

Phrase: "*P <0.03,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "*"

Phrase: "*P <0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "("

Phrase: "[chi]2 with Yates' correction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1705565:CORRECTION [Intellectual Product]
   760   C1720589:Chi [Intellectual Product]
   760   C1947976:Correction [Functional Concept]

Phrase: ")"

Phrase: "versus"

Phrase: "controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.40: aAges were at death, if status confirmed, but at last clinical assessment for living subjects. 

Phrase: "aAges"

Phrase: "were at death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011065:Death [Organism Function]
   790   C1306577:Death, NOS [Finding]

Phrase: "if"

Phrase: "status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449438:Status [Qualitative Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: ","

Phrase: "but at last clinical assessment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205210:Clinical [Qualitative Concept]
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "for living subjects."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C1552741:living subject [Idea or Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.41: Table 2 Odds ratios of confirmed late-onset Alzheimer's disease for BCHE-K alleles Subjects Controls Cases Odds ratioa 95% C.I. 

Phrase: "Table 2 Odds ratios of confirmed late-onset Alzheimer's disease"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0028873:Odds Ratios [Quantitative Concept]
   739   C0456603:Ratios [Quantitative Concept]
   739   C1610540:*Ratios [Quantitative Concept]
   706 E C1547037:Ratio [Intellectual Product]

Phrase: "for BCHE-K alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "Cases Odds ratioa 95% C.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0021966:I- [Inorganic Chemical]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.42: All >65 years 104 74 2.15 1.1-4.25 All >75 years 68 36 2.7 1.1-6.8 ApoE [epsilon]4 carriers >65 years 32 52 6.9 1.65-29 ApoE [epsilon]4 carriers >75 years 22 24 12.8 1.9-86 Ages in Tables 2-5 were at onset for late-onset AD cases and for controls at death, if confirmed, but at last clinical assessment if living. 

Phrase: "All >65 years 104 74 2.15 1.1-4.25"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0439234:years [Temporal Concept]
   790   C0450385:65 [Intellectual Product]
   756 E C0439508:/year [Temporal Concept]

Phrase: "All >75 years 68 36 2.7 1.1-6.8 ApoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   788   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C0523511:APOE [Laboratory Procedure]
   788   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: ">65 years 32 52 6.9 1.65-29 ApoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0523511:APOE [Laboratory Procedure]
   790   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: ">75 years 22 24 12.8 1.9-86 Ages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001779:Age [Organism Attribute]

Phrase: "in Tables 2-5"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0039224:tables [Manufactured Object]
   827   C1706074:Tables [Intellectual Product]
   793 E C1706073:Table [Medical Device]

Phrase: "were at onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332162:Onset [Qualitative Concept]

Phrase: "for late-onset AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]

Phrase: "and for controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1515981:And [Idea or Concept]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "at death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "if"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: ","

Phrase: "but at last clinical assessment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205210:Clinical [Qualitative Concept]
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "if"

Phrase: "living."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376558:Living [Idea or Concept]
Processing 00000000.tx.43: aThese odds ratios were based on alleles. 

Phrase: "aThese odds ratios"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0028873:Odds Ratios [Quantitative Concept]
   827   C0456603:Ratios [Quantitative Concept]
   827   C1610540:*Ratios [Quantitative Concept]
   793 E C1547037:Ratio [Intellectual Product]

Phrase: "were"

Phrase: "based on alleles."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0002085:Alleles [Gene or Genome]
   790   C1527178:Based [Functional Concept]
   790   C1705938:Based [Idea or Concept]
   756 E C0002055:base [Inorganic Chemical]
   756 E C0178499:Base [Chemical Viewed Functionally]
   756 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.44: The equivalent odds ratios for BCHE-K based on carriers were: 2.3, 2.6, 7.9 and 15.0. 

Phrase: "The equivalent odds ratios for BCHE-K"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratios [Quantitative Concept]
   753   C0456603:Ratios [Quantitative Concept]
   753   C1610540:*Ratios [Quantitative Concept]
   719 E C1547037:Ratio [Intellectual Product]

Phrase: "based on carriers"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   790   C0007294:carriers [Finding]
   790   C1527178:Based [Functional Concept]
   790   C1705938:Based [Idea or Concept]
   756 E C0002055:base [Inorganic Chemical]
   756 E C0178499:Base [Chemical Viewed Functionally]
   756 E C0560175:Carrier [Finding]
   756 E C1706209:Carrier [Medical Device]
   756 E C1880279:Base [Biomedical or Dental Material]
   756 E C3273162:Carrier [Intellectual Product]

Phrase: "were"

Phrase: ":"

Phrase: "2.3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1519042:2-3 [Research Activity]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "2.6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "7.9"

Phrase: "and"

Phrase: "15.0."
Processing 00000000.tx.45: Table 3 Odds ratios of confirmed late-onset Alzheimer's disease for APOE [epsilon]4 alleles Subjects Controls Cases Odds ratio 95% C.I. 

Phrase: "Table 3 Odds ratios of confirmed late-onset Alzheimer's disease"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0028873:Odds Ratios [Quantitative Concept]
   739   C0456603:Ratios [Quantitative Concept]
   739   C1610540:*Ratios [Quantitative Concept]
   706 E C1547037:Ratio [Intellectual Product]

Phrase: "for APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "Cases Odds ratio 95% C.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0021966:I- [Inorganic Chemical]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.46: All >65 years 104 74 3.6 2.2-5.9 All >75 years 68 36 2.8 1.4-5.5 BCHE-K carriers >65 years 17 23 12.3 2.6-58 BCHE-K carriers >75 years 11 12 15.0 1.95-115 Table 4 Proportions of controls and confirmed late-onset AD cases with both BCHE-K and APOE [epsilon]4 alleles Subjects Proportions with both alleles  Controls Cases P* All >65 years 2/104 (2%) 18/74 (24%) <0.0001 All >75 years 1/68 (1%) 10/36 (28%) <0.0001 APOE [epsilon]4 carriers >65 years 2/32 (6%) 18/52 (35%) 0.007 APOE [epsilon]4 carriers >75 years 1/22 (5%) 10/24 (42%) 0.009 *[chi]2 with Yates' correction. 

Phrase: "All >65 years 104 74 3.6 2.2-5.9"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0439234:years [Temporal Concept]
   790   C0450385:65 [Intellectual Product]
   756 E C0439508:/year [Temporal Concept]

Phrase: "All >75 years 68 36 2.8 1.4-5.5 BCHE-K carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   787   C0007294:carriers [Finding]
   754 E C0560175:Carrier [Finding]
   754 E C1706209:Carrier [Medical Device]
   754 E C3273162:Carrier [Intellectual Product]

Phrase: ">65 years 17 23 12.3 2.6-58 BCHE-K carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   788   C0007294:carriers [Finding]
   755 E C0560175:Carrier [Finding]
   755 E C1706209:Carrier [Medical Device]
   755 E C3273162:Carrier [Intellectual Product]

Phrase: ">75 years 11 12 15.0 1.95-115 Table 4 Proportions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   754   C1709707:Proportion [Quantitative Concept]
   704 E C0205351:Proportional [Qualitative Concept]

Phrase: "of controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "late-onset AD cases with both BCHE-K"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "Proportions with both alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1709707:Proportion [Quantitative Concept]

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "Cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "P*"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "All >65 years 2/104"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0439234:years [Temporal Concept]
   812   C0450385:65 [Intellectual Product]
   779 E C0439508:/year [Temporal Concept]

Phrase: "(2%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "18/74"

Phrase: "(24%"

Phrase: ")"

Phrase: "<0.0001"

Phrase: "All >75 years 1/68"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0439234:years [Temporal Concept]
   812   C0450387:68 [Intellectual Product]
   779 E C0439508:/year [Temporal Concept]

Phrase: "(1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "10/36"

Phrase: "(28%"

Phrase: ")"

Phrase: "<0.0001 APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0523511:APOE [Laboratory Procedure]
   827   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: ">65 years 2/32"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0439234:years [Temporal Concept]
   812   C0450385:65 [Intellectual Product]
   779 E C0439508:/year [Temporal Concept]

Phrase: "(6%"

Phrase: ")"

Phrase: "18/52"

Phrase: "(35%"

Phrase: ")"

Phrase: "0.007 APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0523511:APOE [Laboratory Procedure]
   827   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: ">75 years 1/22"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: "(5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "10/24"

Phrase: "(42%"

Phrase: ")"

Phrase: "0.009"

Phrase: "*"

Phrase: "[chi]2 with Yates' correction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1705565:CORRECTION [Intellectual Product]
   760   C1720589:Chi [Intellectual Product]
   760   C1947976:Correction [Functional Concept]
Processing 00000000.tx.47: Table 5 Odds ratios of confirmed late-onset AD, taking subjects who had neither APOE [epsilon]4 nor BCHE-K as the reference APOE [epsilon]4 BCHE-K Controls Cases Odds ratio 95% CI Age >65 years - - 57 17 Reference  - + 15 5 1.1 NS + - 30 34 3.8 1.8-8.1 + + 2 18 30.2 8.4-108 Age >75 years - - 36 10 Reference  - + 10 2 0.7 NS + - 21 14 2.4 0.8-7.3 (NS) + + 1 10 36.0 6.1-211 In order to examine further the strength of the interaction between BCHE-K and APOE [epsilon]4, we give in Table 5 the odds ratios of confirmed AD for subjects with different combinations of these two genes, taking subjects who have neither gene as the reference. 

Phrase: "Table 5 Odds ratios of confirmed late-onset AD,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   764   C0028873:Odds Ratios [Quantitative Concept]
   742   C0456603:Ratios [Quantitative Concept]
   742   C1610540:*Ratios [Quantitative Concept]
   708 E C1547037:Ratio [Intellectual Product]

Phrase: "taking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "who"

Phrase: "had"

Phrase: "neither APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4"

Phrase: "nor"

Phrase: "BCHE-K as the reference APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 BCHE-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "Cases Odds ratio 95% CI Age >65 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   822   C1510829:Age-Years [Temporal Concept]
   793   C0439234:years [Temporal Concept]
   760 E C0439508:/year [Temporal Concept]

Phrase: "- -"

Phrase: "57 17 Reference  - + 15 5 1.1 NS + - 30 34 3.8 1.8-8.1 + + 2 18 30.2 8.4-108 Age >75 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1510829:Age-Years [Temporal Concept]
   782   C0439234:years [Temporal Concept]
   748 E C0439508:/year [Temporal Concept]

Phrase: "- -"

Phrase: "36 10 Reference  - + 10 2 0.7 NS + - 21 14 2.4 0.8-7.3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C1883310:10^3 [Quantitative Concept]
   841   C0163702:NS-3 [Organic Chemical,Pharmacologic Substance]
   793   C0537772:NS 21 [Organic Chemical,Pharmacologic Substance]
   785   C1514811:Reference [Idea or Concept]
   785   C1706462:Reference [Conceptual Entity]

Phrase: "(NS) + + 1 10 36.0 6.1-211"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   836   C0439187:/10^6 [Quantitative Concept]
   836   C1881839:10^6 [Quantitative Concept]
   812   C0165193:NS-1 [Organic Chemical,Pharmacologic Substance]
   812   C1424660:NS-1 [Gene or Genome]

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "examine"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "the strength of the interaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0237897:Strength [Quantitative Concept]
   760   C0808080:Strength [Idea or Concept]
   760   C1705922:Strength [Qualitative Concept]

Phrase: "between BCHE-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "and"

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4,"

Phrase: "we"

Phrase: "give in Table 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C1947971:Give [Functional Concept]

Phrase: "the odds ratios of confirmed AD"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratios [Quantitative Concept]
   753   C0456603:Ratios [Quantitative Concept]
   753   C1610540:*Ratios [Quantitative Concept]
   719 E C1547037:Ratio [Intellectual Product]

Phrase: "for subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "with different combinations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0453882:Combinations [Manufactured Object]
   827 E C0205195:Combination [Qualitative Concept]
   827 E C1947911:Combination [Physical Object]

Phrase: "of these two genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "taking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "who"

Phrase: "have"

Phrase: "neither gene as the reference."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.48: In subjects over 65 years, the odds ratio in those who only carry BCHE-K was 1.1 and in those with only APOE [epsilon]4 it was 3.8. 

Phrase: "In subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "over 65 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "the odds ratio in those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0028873:Odds Ratio [Quantitative Concept]
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "who only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "BCHE-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "was"

Phrase: "1.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and in those with only APOE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205171:Only [Quantitative Concept]
   753   C0523511:APOE [Laboratory Procedure]
   753   C1412481:APOE [Gene or Genome]
   753   C1515981:And [Idea or Concept]
   753   C1720467:Only [Intellectual Product]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4"

Phrase: "it"

Phrase: "was"

Phrase: "3.8."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]
Processing 00000000.tx.49: This gave a predicted odds ratio of 4.2 in subjects with both genes, on the assumption of independent effects of the two genes, compared with the observed value of 30.2. 

Phrase: "This"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a predicted odds ratio of 4.2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0028873:Odds Ratio [Quantitative Concept]
   748   C0456603:Ratio [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]

Phrase: "in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "with both genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "on the assumption"

Phrase: "of independent effects"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0085862:Independent [Idea or Concept]
   861   C1280500:effects [Qualitative Concept]
   861   C1299583:Independent [Finding]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "of the two genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "compared with the observed value of 30.2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1441672:Observed [Functional Concept]
   744   C1522609:Value [Quantitative Concept]
   744   C1707455:Compared [Activity]
Processing 00000000.tx.50: In subjects over 75 years, the predicted odds ratio was 1.7, but the observed odds ratio was 36. 

Phrase: "In subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "over 75 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "the predicted odds ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0028873:Odds Ratio [Quantitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "1.7,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3541329:1-7 [Gene or Genome]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "but"

Phrase: "the observed odds ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0028873:Odds Ratio [Quantitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "36."
Processing 00000000.tx.51: We therefore suggest that there is strong synergy between these two alleles in late-onset AD. 

Phrase: "We therefore"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "is"

Phrase: "strong synergy between these two alleles"

Phrase: "in late-onset AD."
Processing 00000000.tx.52: DISCUSSION That APOE [epsilon]4 is a risk factor for AD is well established (12 ,13 ). 

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "That APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4"

Phrase: "is"

Phrase: "a risk factor for AD"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0035648:Risk factor [Quantitative Concept]
   797   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   797   C0960756:factor A [Organic Chemical]
   760   C0035647:Risk [Qualitative Concept]
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "well established"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205170:Well [Qualitative Concept]
   861   C0443211:Established [Qualitative Concept]
   861   C1272684:Established [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "(12 ,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.53: Our results are consistent with the hypothesis that BCHE-K is associated with a further increase in the risk of late-onset AD in APOE [epsilon]4 carriers. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with the hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that BCHE-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "is"

Phrase: "associated with a further increase"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0442805:Increase [Functional Concept]
   760   C1517331:Further [Spatial Concept]
   726 E C0205108:far [Spatial Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "of late-onset AD"

Phrase: "in APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 carriers."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]
Processing 00000000.tx.54: The effect could be due to linkage disequilibrium with another gene on chromosome 3, conceivably transferrin, whose C2 variant was reported to be more common in 20 clinically diagnosed AD cases than in the general population (14 ). 

Phrase: "The effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "could"

Phrase: "be due to linkage disequilibrium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   806   C0678226:Due to [Functional Concept]
           due
   760   C0023745:linkage [Molecular Function]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]

Phrase: "with another gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "on chromosome 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008666:Chromosome 3 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "conceivably transferrin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "whose C2 variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "more common in 20 clinically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205214:Common [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "AD cases than"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0868928:Cases [Functional Concept]
   790   C1533148:Cases [Quantitative Concept]
   756 E C1706255:CASE [Medical Device]
   756 E C1706256:Case [Conceptual Entity]

Phrase: "in the general population"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683971:General Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.55: BCHE is at 3q26.1-q26.2 (15 ), while the gene for transferrin is at 3q21-q25 (16 ). 

Phrase: "BCHE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:BCHE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BCHE [Gene or Genome]

Phrase: "is at 3q26.1-q26.2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C1521322:3q26.1-q26.2 [Cell Component]
   790   C2825757:3q26.1 [Cell Component]
   753   C1521321:3q26 [Cell Component]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "the gene for transferrin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1442762:Transferrin Gene [Gene or Genome]
   770   C0017337:Gene [Gene or Genome]

Phrase: "is at 3q21-q25"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1521308:3q21-q25 [Cell Component]
   770   C1521305:3q21 [Cell Component]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.56: On the other hand, the effect on late-onset AD might be mediated by BCHE-K itself. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "the effect on late-onset AD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0543419:late effect [Finding]
   783   C1368999:Late effect [Pathologic Function]
   783   C1883473:Ad Effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "might"

Phrase: "be"

Phrase: "mediated by BCHE-K"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "itself."
Processing 00000000.tx.57: Biological plausibility There are various potential interactions between BChE and apolipoprotein E (apoE). 

Phrase: "Biological plausibility There"

Phrase: "are"

Phrase: "various potential interactions between BChE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "apolipoprotein E (apoE)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.58: Both proteins are produced in quantity in the liver and secreted into the circulation (1 ,17 ). 

Phrase: "Both proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "produced in quantity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1265611:Quantity [Quantitative Concept]
   790   C1554108:Quantity [Intellectual Product]
   790   C1561573:Quantity [Intellectual Product]

Phrase: "in the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "secreted into the circulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005775:Circulation [Physiologic Function]
   770   C1327616:Secreted [Cell Function]
   770   C1516559:Circulation [Organism Function]

Phrase: "(1 ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.59: Not only apoE, but probably also BChE, interact with lipoproteins (18 ,19 ). 

Phrase: "Not only apoE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "probably also BChE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "interact with lipoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(18 ,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.60: Both proteins are found in astrocytes (20 ,21 ) and in other glia, BChE in oligodendrocytes (22 ) and apoE in microglia (23 ). 

Phrase: "Both proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "found in astrocytes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0004112:Astrocytes [Cell]
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "(20 ,"

Phrase: "21"

Phrase: ")"

Phrase: "and in other glia,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0027836:Glia [Cell]
   770   C1087003:Glia [Plant]
   770   C1515981:And [Idea or Concept]

Phrase: "BChE in oligodendrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "(22"

Phrase: ")"

Phrase: "and"

Phrase: "apoE in microglia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.61: Both proteins occur in AD in plaques, intra- and extracellular neurofibrillary tangles and in association with amyloid angiopathy (7 ,8 ,24 ,25 ). 

Phrase: "Both proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "occur in AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "in plaques,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "intra-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0347985:Intra [Temporal Concept]

Phrase: "and"

Phrase: "extracellular neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and in association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]
   790   C1515981:And [Idea or Concept]

Phrase: "with amyloid angiopathy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2931784:Amyloid angiopathy [Disease or Syndrome]
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0042373:Angiopathy [Disease or Syndrome]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(7 ,"

Phrase: "8 ,"

Phrase: "24 ,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.62: Furthermore, both BChE and apoE have been implicated in certain models of neurite growth (26 -31 ). 

Phrase: "Furthermore,"

Phrase: "both BChE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "and"

Phrase: "apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in certain models of neurite growth"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1753129:neurite growth [Cell Function]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0085103:Neurite [Cell Component]
   748   C0220844:growth [Physiologic Function]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2911660:Growth [Activity]
   748   C3161035:Models [Intellectual Product]

Phrase: "(26 -31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.63: In the case of apoE, there are differences between the E3 and E4 isoforms (29 -31 ) and, in the case of BChE, it has been suggested that the nature of the attached sugar residues may be important (26 -28 ). 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of apoE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "there"

Phrase: "are"

Phrase: "differences between the E3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "E4 isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "(29 -31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: ","

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of BChE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the nature of the attached sugar residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0349590:Nature [Idea or Concept]
   748   C1262865:Nature [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "important"

Phrase: "(26 -28"

Phrase: ")."
Processing 00000000.tx.64: It should be noted that the K variant of BChE has an additional threonine residue at position 539, but whether this is a potential O-glycosylation site (or, indeed, a phosphorylation site) remains to be shown. 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the K variant of BChE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variant [Qualitative Concept]

Phrase: "has"

Phrase: "an additional threonine residue at position 539,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1709915:Residue [Conceptual Entity]
   748   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "but"

Phrase: "whether"

Phrase: "this"

Phrase: "is"

Phrase: "a potential O-glycosylation site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0017982:glycosylation [Natural Phenomenon or Process]
   812   C0205145:Site [Spatial Concept]
   812   C0376322:Glycosylation [Molecular Function]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "("

Phrase: "or"

Phrase: ","

Phrase: "indeed,"

Phrase: "a phosphorylation site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1519063:Phosphorylation Site [Amino Acid Sequence]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C0205145:Site [Spatial Concept]
   861   C1158886:Phosphorylation [Molecular Function]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: ")"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.65: Furthermore, a threonine residue has a high propensity for [beta]-sheet formation (32 ). 

Phrase: "Furthermore,"

Phrase: "a threonine residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "has"

Phrase: "a high propensity for"

Phrase: "[beta]-sheet formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0599215:Beta Sheet [Cell Component]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.66: In lysozyme, conversion of an isoleucine residue to threonine causes amyloidosis (33 ), as does conversion of an alanine residue to threonine in transthyretin (34 ). 

Phrase: "In lysozyme,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026794:Lysosyme [Enzyme,Pharmacologic Substance]
  1000   C1416945:LYSOZYME [Gene or Genome]
  1000   C3541379:lysozyme [Enzyme,Pharmacologic Substance]

Phrase: "conversion of an isoleucine residue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439836:Conversion [Functional Concept]

Phrase: "to threonine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "amyloidosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "does"

Phrase: "conversion of an alanine residue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439836:Conversion [Functional Concept]

Phrase: "to threonine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "in transthyretin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032923:Transthyretin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1421224:TRANSTHYRETIN [Gene or Genome]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.67: The evidence cited provides pointers for future work to test the hypothesis that BChE and apoE may interact and that this interaction is influenced by their allelic variants. 

Phrase: "The evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "cited"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "pointers for future"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0324413:pointers [Mammal]
   756 E C1704635:Pointer [Manufactured Object]
   756 E C1704636:Pointer [Intellectual Product]

Phrase: "work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that BChE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "and"

Phrase: "apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "interact"

Phrase: "and"

Phrase: "that"

Phrase: "this interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "is"

Phrase: "influenced by their allelic variants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:variants [Qualitative Concept]
Processing 00000000.tx.68: Implications for clinical genetics Replication of our findings is particularly important since ~6% of the Caucasian population carry both BCHE-K and APOE [epsilon]4, assuming respective allelic frequencies of 0.12 (9 -11 ) and 0.15 (17 ,35 ). 

Phrase: "Implications for clinical genetics Replication of our findings"

Phrase: "is"

Phrase: "particularly important"

Phrase: "since"

Phrase: "~6% of the Caucasian population"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0007457:Caucasian [Population Group]
   760   C0032659:Population [Quantitative Concept]
   760   C0043157:Caucasian [Population Group]
   760   C1257890:Population [Population Group]

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "both BCHE-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "and"

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4,"

Phrase: "assuming"

Phrase: "respective allelic frequencies of 0.12"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   773   C0017270:allelic frequency [Quantitative Concept]
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]

Phrase: "(9 -11"

Phrase: ")"

Phrase: "and"

Phrase: "0.15"

Phrase: "(17 ,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.69: Thus, subject to confirmation of our results, several millions of the elderly who carry both these genes are at high risk of developing AD, especially when aged over 75 years. 

Phrase: "Thus,"

Phrase: "subject to confirmation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0521091:confirmation [Qualitative Concept]
  1000   C0750484:Confirmation [Idea or Concept]

Phrase: "of our results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "several millions of the elderly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1881839:Million [Quantitative Concept]

Phrase: "who"

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "both these genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "are at high risk of developing AD,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0332167:High risk of [Qualitative Concept]
           High Risk
   778   C3272283:High Risk [Finding]
   748   C0035647:Risk [Qualitative Concept]
   748   C0205250:High [Qualitative Concept]
   748   C1299351:High [Qualitative Concept]
   748   C1551058:Are [Quantitative Concept]
   748   C2700149:HIGH [Intellectual Product]

Phrase: "especially"

Phrase: "when"

Phrase: "aged over 75 years."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   802   C1510829:Age-Years [Temporal Concept]
   770   C0001779:Aged [Organism Attribute]
   770   C0001792:Aged [Population Group]
   770   C0439234:years [Temporal Concept]
   770   C1999167:aged [Population Group]
   737 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.70: As pointed out by Roses (36 ), the ability to identify such at-risk individuals has major social and ethical implications. 

Phrase: "As"

Phrase: "pointed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552961:Point [Quantitative Concept]
   966   C2347617:point [Quantitative Concept]

Phrase: "out by Roses"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0035853:Roses [Plant]
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]
   756 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "(36"

Phrase: ")"

Phrase: ","

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "identify"

Phrase: "such at-risk individuals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0027361:Individual [Population Group]
   793   C0237401:Individual [Human]
   734   C1444641:At risk [Qualitative Concept]

Phrase: "has"

Phrase: "major social"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0728831:Social [Functional Concept]

Phrase: "and"

Phrase: "ethical implications."
Processing 00000000.tx.71: Since APOE [epsilon]4 is an established risk factor for cardiovascular disease, it will be important to see whether carriers who also have BCHE-K are at greater risk of cardiovascular disease. 

Phrase: "Since"

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4"

Phrase: "is"

Phrase: "an established risk factor for cardiovascular disease,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0850624:cardiovascular risk factor [Disease or Syndrome]
   804   C0850664:disease risk factor [Finding]
   778   C0035648:Risk factor [Quantitative Concept]
   774   C0679238:disease factor [Functional Concept]
   774   C1281905:disease risk [Finding]
   748   C0035647:Risk [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "it"

Phrase: "will"

Phrase: "be"

Phrase: "important to"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "whether"

Phrase: "carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0007294:carriers [Finding]
   966 E C0560175:Carrier [Finding]
   966 E C1706209:Carrier [Medical Device]
   966 E C3273162:Carrier [Intellectual Product]

Phrase: "who also"

Phrase: "have"

Phrase: "BCHE-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "are at greater risk of cardiovascular disease."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0007222:Cardiovascular disease [Disease or Syndrome]
   774   C1281905:disease risk [Finding]
   748   C0007226:Cardiovascular [Body System]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0035647:Risk [Qualitative Concept]
   748   C0443228:greater [Quantitative Concept]
   748   C1551058:Are [Quantitative Concept]
   748   C1704243:Greater [Quantitative Concept]
   714 E C0549177:Great [Quantitative Concept]
Processing 00000000.tx.72: Such a study would not only have clinical relevance but could also increase our understanding about the role of vascular risk factors (37 ) in the aetiology of AD. 

Phrase: "Such"

Phrase: "a study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "would"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "have"

Phrase: "clinical relevance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevance [Qualitative Concept]

Phrase: "but"

Phrase: "could"

Phrase: "also"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "our understanding about the role of vascular risk factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0162340:Understanding [Mental Process]

Phrase: "(37"

Phrase: ")"

Phrase: "in the aetiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:aetiology [Functional Concept]
  1000   C1314792:Aetiology [Functional Concept]
  1000   C1524003:Etiology [Conceptual Entity]

Phrase: "of AD."
Processing 00000000.tx.73: MATERIALS AND METHODS We examined 282 Caucasians from the Oxford region recruited into the Oxford Project to Investigate Memory and Ageing (OPTIMA) (38 ). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "282 Caucasians from the Oxford region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0007457:Caucasians [Population Group]
   753   C0043157:Caucasians [Population Group]

Phrase: "recruited into the Oxford Project to Investigate Memory and Ageing"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0001811:Ageing [Organism Function]
   739   C0025260:Memory [Mental Process]
   739   C0700327:memory [Finding]
   739   C1292732:investigate [Functional Concept]
   739   C1706377:Memory [Manufactured Object]
   739   C1709701:Project [Conceptual Entity]

Phrase: "(OPTIMA"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   795   C0001811:Ageing [Organism Function]
   795   C0025260:Memory [Mental Process]
   795   C0700327:memory [Finding]
   795   C1292732:investigate [Functional Concept]
   795   C1706377:Memory [Manufactured Object]
   795   C1709701:Project [Conceptual Entity]
   740 E C0679055:mnemonic [Mental Process]

Phrase: ")"

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.74: Eighty eight were autopsy confirmed CERAD (39 ) `definite or probable' AD cases (74 late-, i.e. >65 years, and 14 early-onset), 29 were pathologically confirmed cases of other dementias (12 vascular, five Parkinson's, five non-specific neurodegeneration, three Pick's, and one each of progressive supranuclear palsy, normal pressure hydrocephalus, Huntington's and glioma), 61 were living cases diagnosed `possible AD' or `probable AD' by NINCDS/ADRDA (40 ) criteria (31 late- and 30 early-onset) and 104 were controls without cognitive impairment with CAMDEX (41 ) scores >80 (14 had died and had no AD pathology on necropsy). 

Phrase: "Eighty eight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205454:Eight [Quantitative Concept]

Phrase: "were"

Phrase: "autopsy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004398:Autopsy [Diagnostic Procedure]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "CERAD"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   812   C0002395:Alzheimer's Disease [Disease or Syndrome]
   812   C1521724:Alzheimer's Disease [Pathologic Function]
   793   C0012634:Disease [Disease or Syndrome]
   793   C0034975:Registry [Intellectual Product]
   793   C0443211:establish [Qualitative Concept]
   793   C1513822:Consortium [Professional or Occupational Group]
   793   C1880171:Consortium [Professional or Occupational Group]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]

Phrase: "(39"

Phrase: ")"

Phrase: "`definite"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439544:Definite [Qualitative Concept]
  1000   C1704787:Definite [Qualitative Concept]

Phrase: "or"

Phrase: "probable' AD cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   896   C3274649:Probable Case [Qualitative Concept]
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "(74 late-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205087:Late [Temporal Concept]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ">65 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "14 early-onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1833334:Early-onset [Finding]
   827   C0332162:Onset [Qualitative Concept]
   827   C1279919:Early [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "29"

Phrase: "were"

Phrase: "pathologically confirmed cases of other dementias"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0521093:confirmed [Qualitative Concept]
   753   C0750484:Confirmed [Idea or Concept]
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1456348:Confirm [Qualitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "(12 vascular, five Parkinson's,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   712   C1021144:Parkinsonia [Plant]

Phrase: "five non-specific neurodegeneration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "three Pick's,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1707391:Pick [Activity]
   861   C1826583:PICK [Gene or Genome]

Phrase: "and"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "each of progressive supranuclear palsy,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   806   C0270920:Supranuclear palsy [Disease or Syndrome]
   770   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   760   C0205329:Progressive [Functional Concept]
   760   C0522224:Palsy [Finding]
   760   C1457900:Each [Quantitative Concept]

Phrase: "normal pressure hydrocephalus,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0020258:Hydrocephalus, Normal Pressure [Disease or Syndrome]
   827   C0020255:Hydrocephalus [Disease or Syndrome]
   827   C0033095:Pressure [Phenomenon or Process]
   827   C0205307:Normal [Qualitative Concept]
   827   C0439166:% normal [Quantitative Concept]
   827   C0460139:Pressure [Finding]
   827   C1306345:Pressure [Functional Concept]
   827   C1963137:HYDROCEPHALUS [Finding]
   827   C2347086:% Normal [Quantitative Concept]

Phrase: "Huntington's"

Phrase: "and"

Phrase: "glioma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017638:Glioma [Neoplastic Process]
  1000   C0555198:[M]Glioma NOS [Neoplastic Process]
  1000   C2984291:Glioma [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "61"

Phrase: "were"

Phrase: "living cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "`possible AD' or `probable AD' by NINCDS/ADRDA"

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243161:criteria [Intellectual Product]

Phrase: "(31 late-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205087:Late [Temporal Concept]
   861   C0450355:31 [Intellectual Product]

Phrase: "and"

Phrase: "30 early-onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1833334:Early-onset [Finding]
   827   C0332162:Onset [Qualitative Concept]
   827   C1279919:Early [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "104"

Phrase: "were"

Phrase: "controls without cognitive impairment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   770   C0243148:control [Qualitative Concept]
   770   C0684336:Impairment [Pathologic Function]
   770   C1516691:Cognitive [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "with CAMDEX"

Phrase: "(41"

Phrase: ")"

Phrase: "scores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449820:Score [Quantitative Concept]

Phrase: ">80"

Phrase: "(14"

Phrase: "had"

Phrase: "died"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0011065:Died [Organism Function]
  1000   C1546956:Died [Finding]
   928 E C0231800:Expired [Organ or Tissue Function]
   928 E C1704631:Expire [Idea or Concept]
   907 E C0184532:dying [Organism Function]
   907 E C1553404:terminated [Idea or Concept]
   907 E C2348570:Terminated [Functional Concept]

Phrase: "and"

Phrase: "had"

Phrase: "no AD pathology on necropsy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]

Phrase: ")."
Processing 00000000.tx.75: Subjects were genotyped blind to diagnosis, using blood samples, by PCR methods for the atypical and K variants of BCHE (42 ) and for APOE (43 ). 

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "blind to diagnosis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0150108:Blind [Research Activity]
   790   C0456909:Blind [Disease or Syndrome]
   790   C0525065:blind [Patient or Disabled Group]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "blood samples,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "by PCR methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "for the atypical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205182:Atypical [Qualitative Concept]
  1000   C0741302:Atypical [Finding]

Phrase: "and"

Phrase: "K variants of BCHE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205419:variants [Qualitative Concept]

Phrase: "(42"

Phrase: ")"

Phrase: "and for APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0523511:APOE [Laboratory Procedure]
   790   C1412481:APOE [Gene or Genome]
   790   C1515981:And [Idea or Concept]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.76: ACKNOWLEDGEMENTS We especially thank all patients and volunteers, members of OPTIMA, the Department of Neuropathology (Radcliffe Infirmary), Drs M Cortina Borja, R. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We especially"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "all patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "volunteers,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0042960:Volunteers [Professional or Occupational Group]
   966 E C1549078:Volunteer [Idea or Concept]
   966 E C1997894:volunteer [Population Group]

Phrase: "members of OPTIMA,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0680022:members [Population Group]
   708 E C2698041:Member [Professional or Occupational Group]

Phrase: "the Department of Neuropathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587493:Neuropathology department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "(Radcliffe Infirmary"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0221502:infirmary [Health Care Related Organization]

Phrase: ")"

Phrase: ","

Phrase: "Drs M Cortina Borja,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.77: Clarke, I. 

Phrase: "Clarke,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.78: Craig and E. 

Phrase: "Craig"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551776:Craig [Population Group]

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.79: Sim. 

Phrase: "Sim."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420068:SIM [Gene or Genome]
Processing 00000000.tx.80: This work was supported by Bristol-Myers Squibb. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by Bristol-Myers Squibb."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0331797:Bristol-Myers [Health Care Related Organization]
   760   C0331904:Squibb [Health Care Related Organization]
   760   C1521721:Supported [Conceptual Entity]
   726 E C0183683:Support [Medical Device]
Processing 00000000.tx.81: REFERENCES 1 Silver, A. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1 Silver,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0037125:Silver [Element, Ion, or Isotope]
   861   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   861   C1305285:Silver [Qualitative Concept]
   861   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   777 E C0079853:Moon [Geographic Area]
   768 E C0003782:Argyria [Injury or Poisoning]
   768 E C3463959:Argyria [Eukaryote]

Phrase: "A."
Processing 00000000.tx.82: (1974) The Biology of Cholinesterases. 

Phrase: "(1974"

Phrase: ")"

Phrase: "The Biology of Cholinesterases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0005532:Biology [Biomedical Occupation or Discipline]
Processing 00000000.tx.83: North Holland publications, Amsterdam, The Netherlands. 

Phrase: "North Holland publications,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0034036:Publications [Intellectual Product,Manufactured Object]
   793 E C0034037:Publication [Occupational Activity]
   793 E C1704324:Publication [Intellectual Product]

Phrase: "Amsterdam,"

Phrase: "The Netherlands."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands
Processing 00000000.tx.84: 2 Perry, E.K., Perry, R.H., Blessed, G. and Tomlinson, B.E. 

Phrase: "2 Perry,"

Phrase: "E.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Perry,"

Phrase: "R.H.,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0205090:R- [Spatial Concept]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Blessed,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Tomlinson,"

Phrase: "B.E."
Processing 00000000.tx.85: (1978) Changes in brain cholinesterases in senile dementia of the Alzheimer type. 

Phrase: "(1978"

Phrase: ")"

Phrase: "Changes in brain cholinesterases"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0008429:Cholinesterases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1705241:Change [Quantitative Concept]
   737 E C0033791:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   737 E C0728810:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in senile dementia"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0002395:Dementia, Senile [Disease or Syndrome]
  1000   C0011268:Senile dementia [Mental or Behavioral Dysfunction]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0392079:Senile [Finding]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "of the Alzheimer type."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.86: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.87: Appl. 

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.88: Neurobiol., 4, 273-277. 

Phrase: "Neurobiol.,"

Phrase: "4,"

Phrase: "273-277."
Processing 00000000.tx.89: 3 Perry, E.K. 

Phrase: "3 Perry,"

Phrase: "E.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.90: (1980) The cholinergic system in old age and Alzheimer's disease. 

Phrase: "(1980"

Phrase: ")"

Phrase: "The cholinergic system in old age"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0684164:cholinergic system [Biologically Active Substance]
   753   C0449913:System [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.91: Age Ageing, 9, 1-8. 

Phrase: "Age Ageing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001811:Ageing [Organism Function]

Phrase: "9,"

Phrase: "1-8."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]
Processing 00000000.tx.92: MEDLINE Abstract 4 Carson, K.A., Geula, C. and Mesulam, M.-M. 

Phrase: "MEDLINE Abstract 4 Carson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1551667:Carson [Population Group]

Phrase: "K.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Geula,"

Phrase: "C."

Phrase: "and"

Phrase: "Mesulam,"

Phrase: "M.-"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.93: (1991) Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Electron microscopic localization of cholinesterase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "in Alzheimer brain tissue."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0440746:Brain tissue [Tissue]
   901   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0040300:Tissue [Tissue]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.94: Brain Res., 540, 204-208. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "540,"

Phrase: "204-208."
Processing 00000000.tx.95: MEDLINE Abstract 5 Mesulam, M.-M., Carson, K., Price, B. and Geula, C. 

Phrase: "MEDLINE Abstract 5 Mesulam,"

Phrase: "M.-"

Phrase: "M."

Phrase: ","

Phrase: "Carson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551667:Carson [Population Group]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Geula,"

Phrase: "C."
Processing 00000000.tx.96: (1992) Cholinesterases in the amyloid angiopathy of Alzheimer's disease. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Cholinesterases in the amyloid angiopathy of Alzheimer's disease."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0008429:Cholinesterases [Amino Acid, Peptide, or Protein,Enzyme]
   711 E C0033791:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   711 E C0728810:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.97: Ann. 

Phrase: "Ann."
Processing 00000000.tx.98: Neurol., 31, 565-569. 

Phrase: "Neurol.,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "565-569."
Processing 00000000.tx.99: 6 Mesulam, M.-M. and Geula, C. 

Phrase: "6 Mesulam,"

Phrase: "M.-"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Geula,"

Phrase: "C."
Processing 00000000.tx.100: (1994) Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Butyrylcholinesterase reactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0205332:Reactive [Qualitative Concept]

Phrase: "differentiates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205615:differentiate [Qualitative Concept]

Phrase: "the amyloid plaques of aging"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   806   C2936349:Plaques, Amyloid [Acquired Abnormality]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]

Phrase: "from those"

Phrase: "of dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.101: Ann. 

Phrase: "Ann."
Processing 00000000.tx.102: Neurol., 36, 722-727. 

Phrase: "Neurol.,"

Phrase: "36,"

Phrase: "722-727."
Processing 00000000.tx.103: 7 Geula, C. and Mesulam, M.-M. 

Phrase: "7 Geula,"

Phrase: "C."

Phrase: "and"

Phrase: "Mesulam,"

Phrase: "M.-"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.104: (1995) Cholinesterases and the pathology of Alzheimer disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cholinesterases"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0008429:Cholinesterases [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C0033791:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C0728810:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "the pathology of Alzheimer disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.105: Alzheimer Dis. 

Phrase: "Alzheimer Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0451119:DIS [Intellectual Product]
   861   C1444662:DIS [Finding]
Processing 00000000.tx.106: Assoc. 

Phrase: "Assoc."
Processing 00000000.tx.107: Disord., 9 (Suppl. 2), 23-28. 

Phrase: "Disord.,"

Phrase: "9"

Phrase: "(Suppl. 2"

Phrase: ")"

Phrase: ","

Phrase: "23-28."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.108: MEDLINE Abstract 8 Gmez-Ramos, P., Bouras, C. and Morn, M.A. 

Phrase: "MEDLINE Abstract 8 Gmez-Ramos,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bouras,"

Phrase: "C."

Phrase: "and"

Phrase: "Morn,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.109: (1994) Ultrastructural localization of butyrylcholinesterase on neurofibrillary degeneration sites in the brains of aged and Alzheimer's disease patients. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Ultrastructural localization of butyrylcholinesterase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "on neurofibrillary degeneration sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
   734   C0085400:Neurofibrillary degeneration [Acquired Abnormality]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "and"

Phrase: "Alzheimer's disease patients."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.110: Brain Res., 640, 17-24. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "640,"

Phrase: "17-24."
Processing 00000000.tx.111: MEDLINE Abstract 9 Bartels, C.F., Jensen, F.S., Lockridge, O., van der Spek, A.F.L., Rubinstein, H.M., Lubrano, T. and La Du, B.N. 

Phrase: "MEDLINE Abstract 9 Bartels,"

Phrase: "C.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Jensen,"

Phrase: "F.S.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Lockridge,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "van der Spek,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "A.F.L., Rubinstein,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Lubrano,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "La Du,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540681:DU [Idea or Concept]

Phrase: "B.N."
Processing 00000000.tx.112: (1992) DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. 

Phrase: "(1992"

Phrase: ")"

Phrase: "DNA mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with the human butyrylcholinesterase K-variant"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0086418:Human [Human]
   748   C0205419:Variant [Qualitative Concept]
   748   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]
   748   C1708601:K' [Quantitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "its linkage to the atypical variant mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0023745:linkage [Molecular Function]

Phrase: "and"

Phrase: "other polymorphic sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.113: Am. 

Phrase: "Am."
Processing 00000000.tx.114: J. 

Phrase: "J."
Processing 00000000.tx.115: Hum. 

Phrase: "Hum."
Processing 00000000.tx.116: Genet., 50, 1086-1103. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "50,"

Phrase: "1086-1103."
Processing 00000000.tx.117: MEDLINE Abstract 10 Evans, R.T. and Wardell, J. 

Phrase: "MEDLINE Abstract 10 Evans,"

Phrase: "R.T."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0232024:R T [Clinical Attribute]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Wardell,"

Phrase: "J."
Processing 00000000.tx.118: (1984) On the identification and frequency of the J and K cholinesterase phenotypes in a Caucasian population. 

Phrase: "(1984"

Phrase: ")"

Phrase: "On the identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "frequency of the J"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0376249:frequency [Quantitative Concept]
   770   C0439603:Frequency [Temporal Concept]
   770   C0871396:Frequency [Quantitative Concept]
   770   C1561548:Frequency [Qualitative Concept]
   770   C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "K cholinesterase phenotypes in a Caucasian population."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   762   C1278305:Cholinesterase phenotype [Laboratory Procedure]
   757   C1320601:K+ phenotype [Organism Attribute]
   757   C1320602:K- phenotype [Organism Attribute]
   757   C1320603:k- phenotype [Organism Attribute]
   757   C1320604:k+ phenotype [Organism Attribute]
   748   C0031437:Phenotypes [Organism Attribute]
   734 E C1317664:Pseudocholinesterase phenotype [Clinical Attribute]
   714 E C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.119: J. 

Phrase: "J."
Processing 00000000.tx.120: Med. 

Phrase: "Med."
Processing 00000000.tx.121: Genet., 21, 99-102. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "21,"

Phrase: "99-102."
Processing 00000000.tx.122: MEDLINE Abstract 11 Whittaker, M. and Britten, J.J. 

Phrase: "MEDLINE Abstract 11 Whittaker,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Britten,"

Phrase: "J.J."
Processing 00000000.tx.123: (1985) Plasma cholinesterase variants. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Plasma cholinesterase variants."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205419:variants [Qualitative Concept]
   734   C0728810:Plasma cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.124: Family studies of the E1k gene. 

Phrase: "Family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "studies of the E1k gene."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C1273305:Gene studies [Laboratory Procedure]
   760   C0017337:Gene [Gene or Genome]
   760   C0557651:Study [Manufactured Object]
   760   C0947630:studies [Laboratory Procedure]
   760   C1417943:E1K [Gene or Genome]
   760   C2603343:Study [Research Activity]
Processing 00000000.tx.125: Hum. 

Phrase: "Hum."
Processing 00000000.tx.126: Hered., 35, 364-368. 

Phrase: "Hered.,"

Phrase: "35,"

Phrase: "364-368."
Processing 00000000.tx.127: MEDLINE Abstract 12 Saunders, A.M., Strittmatter, W.J., Schmechel, D., St. 

Phrase: "MEDLINE Abstract 12 Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Schmechel,"

Phrase: "D."

Phrase: ","

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.128: George-Hyslop, P.H., Pericak-Vance, M.A., Joo, S.H., Rosi, B.L., Gusella, J.F., Crapper-MacLachlan, D.R., Alberts, M.J., Hulette, C., Crain, B., Goldgaber, D. and Roses, A.D. 

Phrase: "George-Hyslop,"

Phrase: "P.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Pericak-Vance,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Joo,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rosi,"

Phrase: "B.L., Gusella,"

Phrase: "J.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Crapper-MacLachlan,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Alberts,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Hulette,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Crain,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Goldgaber,"

Phrase: "D."

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.129: (1993) Association of apolipoprotein E allele [epsilon]4 with late-onset familial and sporadic Alzheimer's disease. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Association of apolipoprotein E allele"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 with late-onset familial"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0015576:familial [Family Group]
   760   C0205087:Late [Temporal Concept]
   760   C0241888:Familial [Functional Concept]
   760   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "sporadic Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205422:Sporadic [Temporal Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.130: Neurology, 43, 1467-1472. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "43,"

Phrase: "1467-1472."
Processing 00000000.tx.131: MEDLINE Abstract 13 Roses, A.D. 

Phrase: "MEDLINE Abstract 13 Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0035853:Roses [Plant]
   779 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.132: (1996) Apolipoprotein E alleles as risk factors in Alzheimer's disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Apolipoprotein E alleles as risk factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Alleles [Gene or Genome]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.133: Annu. 

Phrase: "Annu."
Processing 00000000.tx.134: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.135: Med., 47, 387-400. 

Phrase: "Med.,"

Phrase: "47,"

Phrase: "387-400."
Processing 00000000.tx.136: MEDLINE Abstract 14 Van Rensburg, S.J., Carstens, M.E., Potocnik, F.C.V., Aucamp, A.K. and Taljaard, J.J.F. 

Phrase: "MEDLINE Abstract 14 Van Rensburg,"

Phrase: "S."

Phrase: "J.,"

Phrase: "Carstens,"

Phrase: "M."

Phrase: "E.,"

Phrase: "Potocnik,"

Phrase: "F.C.V., Aucamp,"

Phrase: "A.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Taljaard,"

Phrase: "J.J.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.137: (1993) Increased frequency of the transferrin C2 subtype in Alzheimer's disease. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Increased frequency of the transferrin C2 subtype"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.138: Neuroreport, 4, 1269-1271. 

Phrase: "Neuroreport,"

Phrase: "4,"

Phrase: "1269-1271."
Processing 00000000.tx.139: MEDLINE Abstract 15 Gaughan, G., Park, H., Priddle, J., Craig, I. and Craig, S. 

Phrase: "MEDLINE Abstract 15 Gaughan,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Priddle,"

Phrase: "J.,"

Phrase: "Craig,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551776:Craig [Population Group]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Craig,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551776:Craig [Population Group]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.140: (1991) Refinement of the localization of human butyrylcholinesterase to chromosome 3q26.1-q26.2 using a PCR-derived probe. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Refinement of the localization of human butyrylcholinesterase"

Phrase: "to chromosome 3q26.1-q26.2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C1521322:3q26.1-q26.2 [Cell Component]
   897   C0008662:Chromosome 2 [Cell Component]
   853   C0008651:Chromosome 1 [Cell Component]
   840   C2825757:3q26.1 [Cell Component]
   804   C0008633:Chromosome [Cell Component]
   804   C1521321:3q26 [Cell Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a PCR-derived probe."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0182400:Probe [Medical Device]
   827   C1704681:Probe [Gene or Genome]
   827   C2347609:Probe [Chemical Viewed Functionally]
   827   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.141: Genomics, 11, 455-458. 

Phrase: "Genomics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "11,"

Phrase: "455-458."
Processing 00000000.tx.142: MEDLINE Abstract 16 Yang, F., Lum, J.B., McGill, J.R., Moore, C.M., Naylor, S.L., van Bragt, P.H., Baldwin, W.D. and Bowman, B.H. 

Phrase: "MEDLINE Abstract 16 Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2945617:yang [Idea or Concept]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Lum,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416936:LUM [Gene or Genome]

Phrase: "J.B.,"

Phrase: "McGill,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Naylor,"

Phrase: "S.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "van Bragt,"

Phrase: "P.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Baldwin,"

Phrase: "W.D."

Phrase: "and"

Phrase: "Bowman,"

Phrase: "B.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.143: (1984) Human transferrin: cDNA characterization and chromosomal localization. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Human transferrin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0040679:Transferrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1442762:TRANSFERRIN [Gene or Genome]
   777 E C3202973:Transferrins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "cDNA characterization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "chromosomal localization."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1657114:chromosome localisation [Biologic Function]
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]
Processing 00000000.tx.144: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.145: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.146: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.147: USA, 81, 2752-2756. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "81,"

Phrase: "2752-2756."
Processing 00000000.tx.148: MEDLINE Abstract 17 Mahley, R.W. 

Phrase: "MEDLINE Abstract 17 Mahley,"

Phrase: "R.W."
Processing 00000000.tx.149: (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "cholesterol transport protein with expanding role in cell biology."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   764   C0007292:Transport protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1159709:cholesterol transport [Cell Function]
   762 E C0599895:protein transport [Cell Function]
   762 E C1159772:Protein Transport [Cell Function]
   742   C0005528:Transport, NOS [Cell Function]
           Biologic Transport
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1317949:Transport [Manufactured Object]
   742   C3495449:transport [Medical Device]
Processing 00000000.tx.150: Science, 240, 622-630. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "240,"

Phrase: "622-630."
Processing 00000000.tx.151: MEDLINE Abstract 18 Lawrence, S.H. and Melnick, P.J. 

Phrase: "MEDLINE Abstract 18 Lawrence,"

Phrase: "S."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Melnick,"

Phrase: "P.J."
Processing 00000000.tx.152: (1961) Enzymatic activity related to human serum beta-lipoprotein: histochemical, immunoelectrophoretic and quantitative studies. 

Phrase: "(1961"

Phrase: ")"

Phrase: "Enzymatic activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2267219:Enzymatic Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "related to human serum beta-lipoprotein"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   790   C0023823:Beta-lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   753   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086418:Human [Human]
   753   C0229671:Serum [Body Substance]
   753   C0330390:Beta [Plant]
   753   C0439096:Beta [Intellectual Product]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C2004068:Beta [Qualitative Concept]
   719 E C0163712:Relate [Organic Chemical]

Phrase: ":"

Phrase: "histochemical, immunoelectrophoretic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   789   C0020997:immunoelectrophoresis [Laboratory Procedure]
   768 E C0010214:Counterimmunoelectrophoresis [Laboratory Procedure]

Phrase: "and"

Phrase: "quantitative studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
Processing 00000000.tx.153: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.154: Soc. 

Phrase: "Soc."
Processing 00000000.tx.155: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.156: Biol. 

Phrase: "Biol."
Processing 00000000.tx.157: Med., 107, 998-1001. 

Phrase: "Med.,"

Phrase: "107,"

Phrase: "998-1001."
Processing 00000000.tx.158: 19 Kutty, K.M., Rowden, G. and Cox, A.R. 

Phrase: "19 Kutty,"

Phrase: "K.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Rowden,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Cox,"

Phrase: "A.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.159: (1973) Interrelationship between serum [beta]-lipoprotein and cholinesterase. 

Phrase: "(1973"

Phrase: ")"

Phrase: "Interrelationship between serum"

Phrase: "[beta]-lipoprotein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0023823:Beta-lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   861   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "and"

Phrase: "cholinesterase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0008429:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0033791:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0728810:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.160: Can. 

Phrase: "Can."
Processing 00000000.tx.161: J. 

Phrase: "J."
Processing 00000000.tx.162: Biochem., 51, 883-887. 

Phrase: "Biochem.,"

Phrase: "51,"

Phrase: "883-887."
Processing 00000000.tx.163: MEDLINE Abstract 20 Wright, C.I., Geula, C. and Mesulam, M.-M. 

Phrase: "MEDLINE Abstract 20 Wright,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1261259:Wright [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "C.I.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1547546:C-I [Classification]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Geula,"

Phrase: "C."

Phrase: "and"

Phrase: "Mesulam,"

Phrase: "M.-"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.164: (1993) Neuroglial cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Neuroglial cholinesterases in the normal brain"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0008429:Cholinesterases [Amino Acid, Peptide, or Protein,Enzyme]
   719 E C0033791:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   719 E C0728810:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and in Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1515981:And [Idea or Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "relationship to plaques,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0439849:Relationship [Qualitative Concept]
   790   C1705630:Relationship [Idea or Concept]
   790   C1706279:Relationship [Idea or Concept]
   790   C3540605:Relationship [Intellectual Product]

Phrase: "tangles,"

Phrase: "and"

Phrase: "patterns of selective vulnerability."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449774:Patterns [Spatial Concept]
Processing 00000000.tx.165: Ann. 

Phrase: "Ann."
Processing 00000000.tx.166: Neurol., 34, 373-384. 

Phrase: "Neurol.,"

Phrase: "34,"

Phrase: "373-384."
Processing 00000000.tx.167: MEDLINE Abstract 21 Diedrich, J.F., Minnigan, H., Carp, R.I., Whitaker, J.N., Race, R., Frey, W. and Haase, A.T. 

Phrase: "MEDLINE Abstract 21 Diedrich,"

Phrase: "J.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Minnigan,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Carp,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007284:carp [Fish]
  1000   C0328038:Carp [Fish]
  1000   C0677526:Carp [Food]

Phrase: "R.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Whitaker,"

Phrase: "J.N., Race,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034510:Race [Population Group]
   827   C1706779:RACE [Gene or Genome]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Frey,"

Phrase: "W."

Phrase: "and"

Phrase: "Haase,"

Phrase: "A.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0193959:a t [Therapeutic or Preventive Procedure]
Processing 00000000.tx.168: (1991) Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Neuropathological changes in scrapie"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "are"

Phrase: "associated with increased expression of apolipoprotein E"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "cathepsin D in astrocytes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332805:CATHEPSIN D [Gene or Genome]
   770   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.169: J. 

Phrase: "J."
Processing 00000000.tx.170: Virol., 65, 4759-4768. 

Phrase: "Virol.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0965991:virol [Lipid]

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "4759-4768."
Processing 00000000.tx.171: MEDLINE Abstract 22 Roessmann, U. and Friede, R.L. 

Phrase: "MEDLINE Abstract 22 Roessmann,"

Phrase: "U."

Phrase: "and"

Phrase: "Friede,"

Phrase: "R.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.172: (1966) Changes in butyryl cholinesterase activity in reactive glia. 

Phrase: "(1966"

Phrase: ")"

Phrase: "Changes in butyryl cholinesterase activity"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   862   C1149831:butyrylcholinesterase activity [Molecular Function]
           cholinesterase activity
   806   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
           Cholinesterase
   806   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]
   760   C0008429:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033791:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205177:Activity [Functional Concept]
   760   C0392747:Change [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0443172:change [Quantitative Concept]
   760   C1561536:*Activity [Idea or Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "in reactive glia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027836:Glia [Cell]
   861   C1087003:Glia [Plant]
Processing 00000000.tx.173: Neurology, 16, 123-129. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "16,"

Phrase: "123-129."
Processing 00000000.tx.174: MEDLINE Abstract 23 Weisgraber, K.H., Pitas, R.E. and Mahley, R.W. 

Phrase: "MEDLINE Abstract 23 Weisgraber,"

Phrase: "K.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Pitas,"

Phrase: "R.E."

Phrase: "and"

Phrase: "Mahley,"

Phrase: "R.W."
Processing 00000000.tx.175: (1994) Lipoproteins, neurobiology, and Alzheimer's disease: structure and function of apolipoprotein E. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Lipoproteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "neurobiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027817:Neurobiology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "function of apolipoprotein E."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]
Processing 00000000.tx.176: Curr. 

Phrase: "Curr."
Processing 00000000.tx.177: Opin. 

Phrase: "Opin."
Processing 00000000.tx.178: Struct. 

Phrase: "Struct."
Processing 00000000.tx.179: Biol., 4, 507-515. 

Phrase: "Biol.,"

Phrase: "4,"

Phrase: "507-515."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450381:507 [Intellectual Product]
Processing 00000000.tx.180: 24 Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E. and Ikeda, K. 

Phrase: "24 Namba,"

Phrase: "Y.,"

Phrase: "Tomonaga,"

Phrase: "M."

Phrase: ","

Phrase: "Kawasaki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Otomo,"

Phrase: "E."

Phrase: "and"

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.181: (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Apolipoprotein E immunoreactivity in cerebral amyloid deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597879:immunoreactivity [Molecular Function]

Phrase: "and"

Phrase: "neurofibrillary tangles in Alzheimer's disease"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   806   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   773 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "kuru plaque amyloid in Creutzfeldt-Jakob disease."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0002726:amyloid disease [Disease or Syndrome]
   774   C0333463:amyloid plaque [Acquired Abnormality]
   774   C2936349:Plaque, Amyloid [Acquired Abnormality]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.182: Brain Res., 541, 163-166. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "541,"

Phrase: "163-166."
Processing 00000000.tx.183: MEDLINE Abstract 25 Rebeck, G.W., Reiter, J.S., Strickland, D.K. and Hyman, B.T. 

Phrase: "MEDLINE Abstract 25 Rebeck,"

Phrase: "G.W., Reiter,"

Phrase: "J.S.,"

Phrase: "Strickland,"

Phrase: "D."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538923:B'-T [Gene or Genome]
Processing 00000000.tx.184: (1993) Apolipoprotein E in sporadic Alzheimer's disease-allelic variation and receptor interactions. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Apolipoprotein E in sporadic Alzheimer's disease-allelic variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "receptor interactions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1372999:Receptor Interactions [Molecular Function]
   827   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.185: Neuron, 11, 575-580. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "11,"

Phrase: "575-580."
Processing 00000000.tx.186: MEDLINE Abstract 26 Layer, P.G. and Kaulich, S. 

Phrase: "MEDLINE Abstract 26 Layer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0934502:Layer [Body Part, Organ, or Organ Component]
   812   C1522408:Layer [Qualitative Concept]
   812   C1561599:Layer [Intellectual Product]

Phrase: "P.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Kaulich,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.187: (1991) Cranial nerve growth in birds is preceded by cholinesterase expression during neural crest cell migration and the formation of an HNK-1 scaffold. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Cranial nerve growth in birds"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0814002:Neural Growth [Cell Function,Organism Function]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]

Phrase: "is"

Phrase: "preceded by cholinesterase expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0008429:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0033791:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0332152:preceded [Temporal Concept]
   770   C0728810:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "during neural crest cell migration"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1326503:neural crest cell migration [Cell Function]
   861   C1622501:Migration, Cell [Cell Function]
   812   C0600210:Migration [Social Behavior]
   812   C1533574:Migration [Physiologic Function]
   812   C1881827:MIGRATION [Phenomenon or Process]
   756   C0815004:Neural crest cell [Cell]
   708   C0027882:Neural cell [Cell]

Phrase: "and"

Phrase: "the formation of an HNK-1 scaffold."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]
Processing 00000000.tx.188: Cell Tissue Res., 265, 393-407. 

Phrase: "Cell Tissue Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: "265,"

Phrase: "393-407."
Processing 00000000.tx.189: MEDLINE Abstract 27 Layer, P.G., Weikert, T. and Alber, R. 

Phrase: "MEDLINE Abstract 27 Layer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0934502:Layer [Body Part, Organ, or Organ Component]
   812   C1522408:Layer [Qualitative Concept]
   812   C1561599:Layer [Intellectual Product]

Phrase: "P.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Weikert,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Alber,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.190: (1993) Cholinesterases regulate neurite growth of chick nerve cells in vitro by means of a non-enzymatic mechanism. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Cholinesterases"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0008429:Cholinesterases [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C0033791:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C0728810:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "regulate"

Phrase: "neurite growth of chick nerve cells"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   809   C0007595:growth of cell [Cell Function]
           cells growth
   790   C1753129:neurite growth [Cell Function]
   756   C0814002:Neural Growth [Cell Function,Organism Function]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2911660:Growth [Activity]

Phrase: "in vitro by means of a non-enzymatic mechanism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0021135:In Vitro [Intellectual Product]
   764   C1533691:in vitro [Qualitative Concept]
           vitro
   764   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.191: Cell Tissue Res., 273, 219-226. 

Phrase: "Cell Tissue Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: "273,"

Phrase: "219-226."
Processing 00000000.tx.192: 28 Layer, P.G. and Willbold, E. 

Phrase: "28 Layer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0934502:Layer [Body Part, Organ, or Organ Component]
   861   C1522408:Layer [Qualitative Concept]
   861   C1561599:Layer [Intellectual Product]

Phrase: "P.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Willbold,"

Phrase: "E."
Processing 00000000.tx.193: (1995) Novel functions of cholinesterases in development, physiology and disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Novel functions of cholinesterases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0542341:Functions [Functional Concept]
   737 E C0031843:function [Physiologic Function]
   737 E C0700205:FUNCTION [Classification]
   737 E C1705273:Function [Intellectual Product]

Phrase: "in development,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "physiology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "and"

Phrase: "disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.194: Prog. 

Phrase: "Prog."
Processing 00000000.tx.195: Histochem. 

Phrase: "Histochem."
Processing 00000000.tx.196: Cytochem., 29 (3), 1-94. 

Phrase: "Cytochem.,"

Phrase: "29"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "1-94."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]
Processing 00000000.tx.197: 29 Nathan, B.P., Bellosta, S., Sanan, D.A., Weisgraber, K.H., Mahley, R.W. and Pitas, R.E. 

Phrase: "29 Nathan,"

Phrase: "B.P.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Bellosta,"

Phrase: "S."

Phrase: ","

Phrase: "Sanan,"

Phrase: "D.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Weisgraber,"

Phrase: "K.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Mahley,"

Phrase: "R.W."

Phrase: "and"

Phrase: "Pitas,"

Phrase: "R.E."
Processing 00000000.tx.198: (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Differential effects of apolipoproteins E3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "E4 on neuronal growth"

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.199: Science, 264, 850-852. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "264,"

Phrase: "850-852."
Processing 00000000.tx.200: 30 Holtzman, D.M., Pitas, R.E., Kilbridge, J., Nathan, B., Mahley, R.W., Bu, G.J. and Schwartz, A.L. 

Phrase: "30 Holtzman,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Pitas,"

Phrase: "R.E.,"

Phrase: "Kilbridge,"

Phrase: "J.,"

Phrase: "Nathan,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Mahley,"

Phrase: "R.W., Bu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006463:BU [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "G.J."

Phrase: "and"

Phrase: "Schwartz,"

Phrase: "A.L."
Processing 00000000.tx.201: (1995) Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Low density lipoprotein receptor-related protein"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   901   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   901   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   895   C0242972:low protein [Therapeutic or Preventive Procedure]
   895   C0748025:low protein [Finding]
   861   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   827   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0178587:density [Quantitative Concept]
   799   C0205251:low [Qualitative Concept]
   799   C0439849:Related [Qualitative Concept]
   799   C0445223:Related [Finding]
   799   C1299352:Low [Qualitative Concept]
   799   C1550472:low [Idea or Concept]
   766 E C0163712:Relate [Organic Chemical]
   727 E C0080103:Relation [Family Group]
   727 E C0439794:Dense [Qualitative Concept]
   727 E C0869014:Relations [Social Behavior]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "apolipoprotein E-dependent neurite outgrowth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C3158384:neurite outgrowth [Cell Function]
   804   C0085103:Neurite [Cell Component]

Phrase: "in a central nervous system-derived neuronal cell line."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   893   C1145640:Central line [Medical Device]
   868   C0027882:nervous system cell [Cell]
           Nerve cell
       E   Neuron
   825   C0682701:Central neuron [Cell]
   823   C0814990:neural cell line [Cell]
   818   C0007600:Cell Line [Cell]
   795   C0007634:Cell [Cell]
   795   C0205132:Line [Spatial Concept]
   795   C0521390:Neuronal [Immunologic Factor]
   795   C1269647:Cell [Cell]
   795   C1550648:Line [Substance]
   795   C1552960:Line [Quantitative Concept]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.202: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.203: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.204: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.205: USA, 92, 9480-9484. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "92,"

Phrase: "9480-9484."
Processing 00000000.tx.206: MEDLINE Abstract 31 Nathan, B.P., Chang, K.-C., Bellosta, S., Brisch, E., Ge, N., Mahley, R.W. and Pitas, R.E. 

Phrase: "MEDLINE Abstract 31 Nathan,"

Phrase: "B.P.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Chang,"

Phrase: "K.-C., Bellosta,"

Phrase: "S."

Phrase: ","

Phrase: "Brisch,"

Phrase: "E.,"

Phrase: "Ge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538705:GE [Gene or Genome]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mahley,"

Phrase: "R.W."

Phrase: "and"

Phrase: "Pitas,"

Phrase: "R.E."
Processing 00000000.tx.207: (1995) The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. 

Phrase: "(1995"

Phrase: ")"

Phrase: "The inhibitory effect of apolipoprotein E4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on neurite outgrowth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3158384:neurite outgrowth [Cell Function]
   861   C0085103:Neurite [Cell Component]

Phrase: "is"

Phrase: "associated with microtubule depolymerization."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1156031:Microtubule Depolymerization [Cell Function]
   770   C0026046:Micro-tubule [Cell Component]
   770   C0301644:Depolymerisation [Phenomenon or Process]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.208: J. 

Phrase: "J."
Processing 00000000.tx.209: Biol. 

Phrase: "Biol."
Processing 00000000.tx.210: Chem., 270, 19791-19799. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "270,"

Phrase: "19791-19799."
Processing 00000000.tx.211: MEDLINE Abstract 32 Minor, D.L. and Kim, P.S. 

Phrase: "MEDLINE Abstract 32 Minor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026193:Minor [Population Group]
   812   C0205165:Minor [Qualitative Concept]

Phrase: "D."

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Kim,"

Phrase: "P.S."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0234833:P s [Organ or Tissue Function]
  1000   C0722388:P & S [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.212: (1994) Measurement of the [beta]-sheet-forming propensities of amino acids. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Measurement of the [beta]-sheet-forming propensities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0242485:Measurement [Functional Concept]

Phrase: "of amino acids."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.213: Nature, 367, 660-663. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "367,"

Phrase: "660-663."
Processing 00000000.tx.214: MEDLINE Abstract 33 Pepys, M.B., Hawkins, P.N., Booth, D.R., Vigushin, D.M., Tennent, G.A., Soutar, A.K., Totty, N., Nguyen, O., Blake, C.C.F., Terry, C.J., Feest, T.G., Zalin, A.M. and Hsuan, J.J. 

Phrase: "MEDLINE Abstract 33 Pepys,"

Phrase: "M.B.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hawkins,"

Phrase: "P.N.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Booth,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Vigushin,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Tennent,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A.,"

Phrase: "Soutar,"

Phrase: "A.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Totty,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Nguyen,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Blake,"

Phrase: "C.C.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Terry,"

Phrase: "C.J.,"

Phrase: "Feest,"

Phrase: "T.G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]

Phrase: "Zalin,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Hsuan,"

Phrase: "J.J."
Processing 00000000.tx.215: (1993) Human lysozyme gene mutations cause hereditary systemic amyloidosis. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Human lysozyme gene mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   875   C0314604:Human gene [Gene or Genome]
   861   C0596611:gene mutations [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "hereditary systemic amyloidosis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0206246:Amyloidosis, Hereditary [Disease or Syndrome]
   901   C0268380:Systemic amyloidosis [Disease or Syndrome]
   901   C0268381:AMYLOIDOSIS, SYSTEMIC [Disease or Syndrome]
   901   C0281479:Systemic Amyloidosis [Neoplastic Process]
   827   C0002726:Amyloidosis [Disease or Syndrome]
Processing 00000000.tx.216: Nature, 362, 553-557. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "362,"

Phrase: "553-557."
Processing 00000000.tx.217: MEDLINE Abstract 34 Saraiva, M.J., Almeida, M., Sherman, W., Gawinowicz, M., Costa, P., Costa, P.P. and Goodman, D.S. 

Phrase: "MEDLINE Abstract 34 Saraiva,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Almeida,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3463949:Almeida [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Sherman,"

Phrase: "W.,"

Phrase: "Gawinowicz,"

Phrase: "M."

Phrase: ","

Phrase: "Costa,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035561:Costa [Body Part, Organ, or Organ Component]
   907 E C1281577:Rib [Body Part, Organ, or Organ Component]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Costa,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035561:Costa [Body Part, Organ, or Organ Component]
   907 E C1281577:Rib [Body Part, Organ, or Organ Component]

Phrase: "P.P."

Phrase: "and"

Phrase: "Goodman,"

Phrase: "D.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.218: (1992) A new transthyretin mutation associated with amyloid cardiomyopathy. 

Phrase: "(1992"

Phrase: ")"

Phrase: "A new transthyretin mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C2985439:new mutation [Cell or Molecular Dysfunction]
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with amyloid cardiomyopathy."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0268407:amyloid cardiomyopathy [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0878544:Cardiomyopathy [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.219: Am. 

Phrase: "Am."
Processing 00000000.tx.220: J. 

Phrase: "J."
Processing 00000000.tx.221: Hum.Genet., 50, 1027-1030. 

Phrase: "Hum.Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "50,"

Phrase: "1027-1030."
Processing 00000000.tx.222: 35 Utermann, G., Steinmetz, A. and Weber, W. 

Phrase: "35 Utermann,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Steinmetz,"

Phrase: "A."

Phrase: "and"

Phrase: "Weber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582525:weber [Quantitative Concept]

Phrase: "W."
Processing 00000000.tx.223: (1982) Genetic control of human apolipoprotein E polymorphism: comparison of one- and two-dimensional techniques of isoprotein analysis. 

Phrase: "(1982"

Phrase: ")"

Phrase: "Genetic control of human apolipoprotein E polymorphism"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0017263:genetic control [Genetic Function]
   774   C0032529:Genetic Polymorphism [Genetic Function]
   751 E C0700589:Birth Control [Therapeutic or Preventive Procedure]
   748   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   748   C0243148:control [Qualitative Concept]
   748   C0314603:Genetic [Functional Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   746   C0086418:Human - origin [Human]

Phrase: ":"

Phrase: "comparison of one-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "two-dimensional techniques of isoprotein analysis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0025664:techniques [Intellectual Product]
   753   C0449851:Techniques [Functional Concept]
Processing 00000000.tx.224: Hum. 

Phrase: "Hum."
Processing 00000000.tx.225: Genet., 60, 344-351. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "60,"

Phrase: "344-351."
Processing 00000000.tx.226: MEDLINE Abstract 36 Roses, A.D. 

Phrase: "MEDLINE Abstract 36 Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0035853:Roses [Plant]
   779 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.227: (1997) A model for susceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "A model for susceptibility polymorphisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "for complex diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.228: Neurogenetics, 1, 3-11. 

Phrase: "Neurogenetics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597047:Neurogenetics [Biomedical Occupation or Discipline]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3-11."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]
Processing 00000000.tx.229: 37 Hoffman, A., Ott, A., Breteler, M.M., Bots, M.L., Slooter, A.J.C., van Harskamp, F., C., v. 

Phrase: "37 Hoffman,"

Phrase: "A.,"

Phrase: "Ott,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1423088:OTT [Gene or Genome]
  1000   C3273338:OTT [Gene or Genome]

Phrase: "A.,"

Phrase: "Breteler,"

Phrase: "M."

Phrase: "M."

Phrase: ","

Phrase: "Bots,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0179376:BOT [Manufactured Object]
   966   C1633989:BOT [Quantitative Concept]

Phrase: "M.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Slooter,"

Phrase: "A.J.C., van Harskamp,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "v."
Processing 00000000.tx.230: D., van Broeckhoven, C. and Grobbee, D.E. 

Phrase: "D."

Phrase: ","

Phrase: "van Broeckhoven,"

Phrase: "C."

Phrase: "and"

Phrase: "Grobbee,"

Phrase: "D."

Phrase: "E."
Processing 00000000.tx.231: (1997) Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Atherosclerosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004153:Atherosclerosis [Disease or Syndrome]
   928 E C0333482:Atherosclerotic [Functional Concept]

Phrase: "apolipoprotein E,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "prevalence of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0033105:Prevalence [Quantitative Concept]
   790   C0220900:prevalence [Quantitative Concept]

Phrase: "and"

Phrase: "Alzheimer's disease in the Rotterdam study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]
Processing 00000000.tx.232: Lancet, 349, 151-154. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "349,"

Phrase: "151-154."
Processing 00000000.tx.233: 38 Jobst, K.A., Smith, A.D., Szatmari, M., Molyneux, A., Esiri, M.M., King, E., Smith, A., Jaskowski, A., McDonald, B. and Wald, N. 

Phrase: "38 Jobst,"

Phrase: "K.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "Szatmari,"

Phrase: "M."

Phrase: ","

Phrase: "Molyneux,"

Phrase: "A.,"

Phrase: "Esiri,"

Phrase: "M."

Phrase: "M."

Phrase: ","

Phrase: "King,"

Phrase: "E.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A.,"

Phrase: "Jaskowski,"

Phrase: "A.,"

Phrase: "McDonald,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Wald,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.234: (1992) Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in life of confirmed Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0150312:In [Quantitative Concept]
   753   C0332285:In [Spatial Concept]
   753   C0376558:Life [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a simple measurement of medial temporal lobe atrophy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0242485:Measurement [Functional Concept]

Phrase: "by computed tomography."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0040405:computed tomography [Diagnostic Procedure]
           tomography
  1000   C1552357:Computed Tomography [Professional or Occupational Group]
   861   C0040395:tomography [Diagnostic Procedure]
   861   C1441526:Computed [Laboratory Procedure]
   861   C1880157:Computed [Activity]
Processing 00000000.tx.235: Lancet, 340, 1179-1183. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "340,"

Phrase: "1179-1183."
Processing 00000000.tx.236: MEDLINE Abstract 39 Mirra, S.S., Heyman, A., McKeel, D., Sumi, S.M., Crain, B.J., Brownlee, L.M., Vogel, F.S., Hughes, J.P., Vanbelle, G. and Berg, L. 

Phrase: "MEDLINE Abstract 39 Mirra,"

Phrase: "S.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Heyman,"

Phrase: "A.,"

Phrase: "McKeel,"

Phrase: "D."

Phrase: ","

Phrase: "Sumi,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Crain,"

Phrase: "B.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Brownlee,"

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Vogel,"

Phrase: "F.S.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Hughes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551730:Hughes [Population Group]

Phrase: "J.P.,"

Phrase: "Vanbelle,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Berg,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.237: (1991) The Consortium to establish a registry for Alzheimer's Disease (CERAD). 

Phrase: "(1991"

Phrase: ")"

Phrase: "The Consortium to establish a registry for Alzheimer's Disease (CERAD)."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   812   C0002395:Alzheimer's Disease [Disease or Syndrome]
   812   C1521724:Alzheimer's Disease [Pathologic Function]
   793   C0012634:Disease [Disease or Syndrome]
   793   C0034975:Registry [Intellectual Product]
   793   C0443211:establish [Qualitative Concept]
   793   C1513822:Consortium [Professional or Occupational Group]
   793   C1880171:Consortium [Professional or Occupational Group]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.238: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.239: Standardization of the neuropathologic assessment of Alzheimer's disease. 

Phrase: "Standardization of the neuropathologic assessment of Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0038136:Standardization [Research Activity]
Processing 00000000.tx.240: Neurology, 41, 479-486. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "41,"

Phrase: "479-486."
Processing 00000000.tx.241: MEDLINE Abstract 40 McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan E.M. 

Phrase: "MEDLINE Abstract 40 McKhann,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Drachman,"

Phrase: "D."

Phrase: ","

Phrase: "Folstein,"

Phrase: "M."

Phrase: ","

Phrase: "Katzman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "and"

Phrase: "Stadlan"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.242: (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services task force of Alzheimer's disease. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Clinical diagnosis of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0332140:Diagnosis, clinical [Qualitative Concept]
   760   C0011900:Diagnosis [Finding]
   760   C0205210:Clinical [Qualitative Concept]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: ":"

Phrase: "report of the NINCDS-ADRDA work group"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0684224:Report [Intellectual Product]
   748   C0700287:Report [Health Care Activity]
   748   C3273238:Report [Intellectual Product]

Phrase: "under the auspices"

Phrase: "of the Department of Health and Human Services task force"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0162458:Task Force [Governmental or Regulatory Activity]
   793   C0441722:Force [Phenomenon or Process]
   793   C0563538:Force [Phenomenon or Process]
   793   C3540678:Task [Occupational Activity]
   756   C0041711:Department of Health and Human Services [Health Care Related Organization]
           department health human services
   737 E C0729333:Dynamic [Functional Concept]

Phrase: "of Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.243: Neurology, 34, 939-944. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "34,"

Phrase: "939-944."
Processing 00000000.tx.244: MEDLINE Abstract 41 Roth, M., Huppert, F.A., Tym, E. and Mountjoy, C.Q. 

Phrase: "MEDLINE Abstract 41 Roth,"

Phrase: "M."

Phrase: ","

Phrase: "Huppert,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "A.,"

Phrase: "Tym,"

Phrase: "E."

Phrase: "and"

Phrase: "Mountjoy,"

Phrase: "C.Q."
Processing 00000000.tx.245: (1988) CAMDEX: The Cambridge Examination for Mental Disorders of the Elderly. 

Phrase: "(1988"

Phrase: ")"

Phrase: "CAMDEX"

Phrase: ":"

Phrase: "The Cambridge Examination for Mental Disorders of the Elderly."
Processing 00000000.tx.246: Cambridge University Press, Cambridge. 

Phrase: "Cambridge University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Cambridge."
Processing 00000000.tx.247: 42 Jensen, F.S., Nielsen, L.R. and Schwartz, M. 

Phrase: "42 Jensen,"

Phrase: "F.S.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Nielsen,"

Phrase: "L.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Schwartz,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.248: (1996) Detection of the plasma cholinesterase K variant by PCR using an amplification-created restriction site. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Detection of the plasma cholinesterase K variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an amplification-created restriction site."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1882940:Restriction Site [Nucleotide Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C0443288:Restriction [Functional Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]
Processing 00000000.tx.249: Hum. 

Phrase: "Hum."
Processing 00000000.tx.250: Hered., 46, 26-31. 

Phrase: "Hered.,"

Phrase: "46,"

Phrase: "26-31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]
Processing 00000000.tx.251: 43 Wenham, P.R., Price, W.H. and Blundell, G. 

Phrase: "43 Wenham,"

Phrase: "P.R.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205090:R- [Spatial Concept]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "W.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Blundell,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.252: (1991) Apolipoprotein E genotyping by one-stage PCR. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Apolipoprotein E genotyping by one-stage PCR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1285573:Genotyping [Laboratory Procedure]
Processing 00000000.tx.253: Lancet, 337, 1158-1159. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "337,"

Phrase: "1158-1159."
Processing 00000000.tx.254: MEDLINE Abstract *To whom correspondence should be addressed. 

Phrase: "MEDLINE Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0000857:Abstract [Occupational Activity]
   861   C0600678:Abstract [Intellectual Product]
   861   C1552863:Abstract [Idea or Concept]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.255: Tel: +44 1865 271883; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+44 1865 271883"

Phrase: ";"
Processing 00000000.tx.256: Fax: +44 1865 271882; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+44 1865 271882"

Phrase: ";"
Processing 00000000.tx.257: Email david.smith@pharm.ox.ac.uk

Phrase: "Email david.smith@pharm.ox.ac.uk"

